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Abstract 
 
CTP Synthase and Transporter Function in Coxiella burnetii 
 
Jeffrey D. Miller 
 
 
Coxiella burnetii is a gram negative, obligate intracellular parasite that can only 
replicate in the acidified environment of a phagosome.  Like other intracellular parasites, 
C. burnetii depends on the host cell for many of the substrates required for growth, such 
as amino acids.  It had been observed that avirulent C. burnetii Nine Mile strain (Phase 
II) organisms in BHK-21 fibroblasts displayed improved growth when extracellular 
cytidine was introduced to infected cultures.  This improved growth was not observed in 
wild type organisms in the same cell system.  This observation, coupled with early 
enzyme activity studies, suggested that Phase II organisms had an inactive CTP synthase 
enzyme.  To verify this hypothesis, nucleoside transport studies were performed in vitro 
in acidified media that determined that both wild type C. burnetii and the avirulent 
variant are permeable to nucleosides, but not nucleotides or nucleobases.  Further, the 
CTP synthase gene from the wild type and avirulent organisms were sequenced and 
compared.  The enzyme activity was examined by using both cell-free extracts and 
hexahistidine-tagged recombinant CTP synthase cloned from the wild type C. burnetii 
genome.  It was found that the Phase I and Phase II CTP synthase genes were identical.  
Further, it was shown that the avirulent organism had a functional CTP synthase enzyme 
and that neither nucleoside transport nor CTP synthase activity were the explanations for 
the lower growth rate of Phase II organisms in BHK-21 fibroblasts.  While the hypothesis 
was found to be invalid, enzyme inhibition experiments suggest the C. burnetii CTP 
synthase may be a potential target for drug development.   
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General Introduction 
Introduction 
Coxiella burnetii is a gram-negative obligate intracellular bacterium that must 
survive and replicate in an acidified phagosome of an infected host cell (Figure 1).  Most 
closely related genetically to Legionella pneumophila, it is a member of the γ-
proteobacteria class in the Legionellales order.  First discovered in the 1930’s in Australia 
and the United States, it is an organism with a world-wide distribution and is the 
causative agent of Query (Q) fever in humans.  C. burnetii, like Chlamydia, has a 
complex life cycle with at least two forms; a metabolically active large cell variant (LCV) 
comparable to the Chlamydia sp. reticulate body, and a spore-like small cell variant 
(SCV) comparable to the Chlamydia sp. elementary body.  Unlike Chlamydia, both cell 
forms are infectious.  Further, the SCV (or another resilient form- see C. burnetii 
Lifecycle Stages) can survive in the environment outside a host for years while remaining 
infectious, and is small enough to be carried and dispersed for miles by wind.  These 
properties have renewed interest in C. burnetii, classified as a category B critical biologic 
agent, as a biological weapon and terror agent.  
A Brief History 
 C. burnetii was discovered in 1935 independently by two research groups in 
Australia and the United States.  That year, an outbreak of undiagnosed febrile illness in 
abattoir (slaughterhouse) workers occurred in Brisbane, Queensland, Australia.  Edward 
Derrick described the illness (named Query or Q fever), and was able to experimentally 
transmit the infection to guinea pigs (Derrick, 1937).  Another researcher, Macfarlane 
Burnet, also reproduced the illness in guinea pigs and other hosts using infected guinea 
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pig spleens provided by Derrick.  Machiavelli-stained spleen sections examined from 
infected animals displayed intracellular vacuoles filled with small rod shapes that 
appeared rickettsial in nature (Derrick, 1937; Maurin & Raoult, 1999).  The researchers 
named the organism Rickettsia burnetii.  Also in 1935, researchers at the Rocky 
Mountain Laboratory in Montana were investigating Rocky Mountain Spotted Fever 
(RMSF) when they established a febrile illness in guinea pigs fed upon by ticks 
(Dermacentor andersoni) obtained at Nine Mile creek in western Montana (Davis & Cox, 
1938).  The symptoms of this illness were unlike RMSF, and it could be passed to 
uninfected guinea pigs by infected blood.  Attempts to grow the etiologic agent in axenic 
media failed.  In 1936, researchers showed that the pathogen could pass through a filter 
much like a virus, and named the organism Rickettsia diaporica because of this ability 
(Davis & Cox, 1938).  Herald Cox was the first to grow the organism in embryonated 
eggs (Cox & Bell, 1939).  In 1938 a lab worker became infected with the ‘Nine-Mile’ 
agent in a lab accident, and his blood could transmit the febrile illness to guinea pigs 
(Dyer, 1938).  Also, the connection with the Australian illness and the organism from 
ticks in Montana was made by experiments where animals inoculated with the Australian 
agent were protected from challenge by the patient’s blood (Dyer, 1938).  The agent was 
renamed Coxiella burnetii to honor the contribution of Cox and Burnet (Philip, 1948).   
Q Fever 
 C. burnetii and Q fever infections have been found throughout the world.  From 
1978 through 2002 in the United States, 538 cases of Q fever were reported by state 
health departments to the Centers for Disease Control and Prevention (unpublished data, 
McQuiston).  The estimated average annual incidence of reported Q fever in the United 
 3
States in humans is 0.09 cases per million population (unpublished data, McQuiston).  Of 
reported cases, 76.2% are male, and 44.4% of the people exposed had contact with 
livestock (unpublished data, McQuiston).  Although the actual number of cases in the 
United States is unknown due to the fact that Q fever has not historically been a 
reportable disease, it was made a nationally reportable disease in 1999, and 45 states 
considered it reportable in 2003.  Diagnosis of Q fever is complicated by the fact that 
many acute infections of Q fever are either asymptomatic, mild, or resemble influenza 
symptoms (Maurin & Raoult, 1999).  Because of the lack of overt or unique symptomatic 
features, the actual incidence of Q fever is severely underreported worldwide, and is 
probably more common than we know.  The incubation period following exposure can 
range from 1 to 3 weeks (McQuiston et al., 2002; Tigertt et al., 1961).  Symptoms of 
acute Q fever are generally nonspecific and could include fever, frontal headache, 
myalgias, and unproductive cough (Fournier et al., 1998; McQuiston et al., 2002).  Other 
symptoms may include light sensitivity, fatigue, rigors, night sweats, nausea and 
vomiting (Maurin & Raoult, 1999).  Roughly 40% of patients were reported with 
granulomatous hepatitis and over 60% with increased liver enzyme activity (McQuiston 
et al., 2002; Raoult et al., 2000).  Approximately one third of patients have pronounced 
respiratory signs such as cough and radiographic changes in the lungs (Marrie, 1988).  Q 
fever has also been linked to complications and abortions during pregnancy (Langley et 
al., 2003; Stein & Raoult, 1998).  The organism has also been isolated from human 
placenta tissue (Syrucek et al., 1958).  Acute Q fever is usually self-limiting, however 
doxycycline has been found effective for treatment (Marrie & Raoult, 2002).  Real-time 
PCR has also shown that C. burnetii is susceptible to tetracycline, rifampicin, and 
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ampicillin (Brennan & Samuel, 2003).  Some patients that are persistently infected with 
C. burnetii will develop chronic Q fever [1-16% of reported patients worldwide 
(Siegman-Igra et al., 1997)] which is most commonly endocarditis, but can also manifest 
as an infection of vascular grafts or aneurysms, osteomyelitis, or hepatitis.  Splenomegaly 
is a common clinical finding.  Endocarditis may be accompanied by clubbing of fingers, 
and prolonged fever (Marrie, 1988; Marrie & Raoult, 2002).  Chronic Q fever is verified 
in the laboratory by the prevalence of Phase I antibodies in the patient’s serum.  Some 
cases of chronic fatigue syndrome have also been associated with persistent infections of 
C. burnetii, with the organism being identified in bone marrow aspirates and liver tissue 
(Ayres et al., 1998; Harris et al., 2000; Marmion et al., 1990).  Treatments of chronic Q 
fever include surgical removal and replacement of infected heart valves, and prolonged 
therapy (up to two years) with doxycycline and hydroxychloroquine (Calza et al., 2002; 
Raoult et al., 1999). 
Vaccine 
 The best preventative measure against contracting Q fever is vaccination.  The 
first vaccine, a formalin-killed and ether-extracted C. burnetii solution in 10% yolk sac, 
was developed by Smadel in 1948 (Smadel et al., 1948).  The current vaccine, Q-VAX® 
(CSL Limited), is a 30 µg dose of formalin-killed C. burnetii Henzerling strain Phase I 
cellular vaccine licensed, used and produced in Australia (Ackland et al., 1994; Marmion 
et al., 1990).  Q fever vaccines are considered experimental in the United States and are 
not freely available to the public.  The United States Army employs a whole-cell killed 
vaccine very similar to the Australian Q-VAX®.  Generally administered to abattoir, 
laboratory, and agriculture-based occupations, C. burnetii vaccines could also play a role 
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in protecting soldiers at risk when occupying regions with histories of high Q fever 
incidences or biological attacks.  Q-VAX® is thought to give protection from Q fever for 
at least 5 years (Ackland et al., 1994).  While nearly 100% effective (Ackland et al., 
1994), the vaccine can have side effects that include subcutaneous abscesses or lipomata 
formations in the area of the vaccine injection if people have already been exposed to C. 
burnetii or been vaccinated before (Marmion et al., 1984; Mills et al., 2003).  These side 
effects can mostly be avoided by eliminating patients who test positive to a skin test or a 
blood antibody titer.  Another vaccine, a chloroform-methanol residue developed in the 
late 1970s by Rocky Mountain Labs, has been tested in human volunteers (Fries et al., 
1993) and at one time was being developed as an alternative to the whole cell vaccine 
(Waag et al., 1997; Waag et al., 2002).  The current status of the chloroform-methanol 
residue vaccine is uncertain.  While it may not have the local reactions that occur with 
administration of killed cellular vaccines such as Q-VAX®, it is unknown if it is as 
effective in preventing aerosolized C. burnetii infections in humans.    
Epidemiology 
Generally, C. burnetii is an organism that infects ruminants, and human infections 
are incidental (Figure 2).  The current “gold standard” used for the detection of a C. 
burnetii antibody titers in the sera of both animals and humans is the indirect 
immunofluorescence assay (IFA) (Field et al., 1983; Peter et al., 1985) (Figure 3).  
Seroprevalence studies of animals in the United States show that goats have more 
frequent exposure to C. burnetii (41.6%) than either sheep (16.5%) or cattle (3.4%) 
(McQuiston & Childs, 2002).  Generally, human infections are initiated from inhaling 
fine particulate matter generated by infected animals during parturition (Welsh et al., 
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1958), or from desiccated urine or fecal matter (McQuiston & Childs, 2002).  It has been 
estimated that 1 gram of infected placental tissue can contain as many as one billion 
organisms (Welsh et al., 1959).  Humans have also been infected by eating contaminated 
milk products (Fishbein & Raoult, 1992).  Occasionally, other infected animals have been 
reported to cause Q fever infections in people, such as cats, dogs, pigeons, and wild 
animals (Buhariwalla et al., 1996; Marrie et al., 1988; McQuiston & Childs, 2002; Stein 
& Raoult, 1999).  There have also been reports of sexual transmission of C. burnetii, but 
this is extremely rare considering other modes of infection (Milazzo et al., 2001).  
Although C. burnetii was originally isolated from ticks and has been identified in at least 
40 species of ticks (Lee et al., 2004; Maurin & Raoult, 1999), the role ticks play in 
transmission of the agent to animals is not completely defined and tick transmission to 
humans is rare.   
While some information is available on the incidence of infection of animals, 
most information comes from outbreaks where significant numbers of animals or humans 
were infected by the organism.  The actual incidence of C. burnetii either worldwide or in 
the United States is unknown and probably under-reported.  Without this information, 
clinicians could have difficulty distinguishing a natural outbreak from an organized, 
intentional release of a biological agent.  More epidemiology studies are required at both 
regional and national levels to understand the natural occurrence of Q fever.  
C. burnetii outbreaks in the military 
 For an agent that was discovered in 1938, C. burnetii has played a surprising role 
in troop illnesses in the military.  There have been thousands of identified cases of Q 
fever in the military across the world, ranging from World War II to the first Persian Gulf 
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War (Byrne, 1997).  The first documented troop illnesses caused by Q fever were 
observed during World War II.  It has been estimated that Q fever in Northern Italy may 
have accounted for roughly 75% of the cases of atypical pneumonia in certain Army 
hospitals (Moe & Pedersen, 1980).  It must be stated that most Q fever cases during 
World War II were not identified by serology, but by symptoms (Byrne, 1997).  
Balkangrippe, an illness in German troops serving during WWII in Bulgaria, Italy 
Crimea, Greece, Ukraine, Corsica, and Yugoslavia, had symptoms that are similar or 
identical to acute infections of Q fever with a mortality rate of less than 1% (Spicer, 
1978).  Over 1000 cases of Balkangrippe were documented by Dr. Dennig, a consultant 
physician to the German forces, during an epidemic in 1941 (Spicer, 1978).  In 1945, the 
causative agent for some cases of Balkangrippe was positively identified as C. burnetii 
(Spicer, 1978).  From December 1944 to June 1945, 1700 troops, mostly stationed in 
Italy, were known to have Q fever (Byrne, 1997; Spicer, 1978).  In those cases contact 
with farm animals was not an absolute requirement (Byrne, 1997).  From 1946-1956, 
Greek armed forces continued to have large numbers of troops hospitalized from Q fever 
infections (Byrne, 1997).  Other smaller outbreaks documented in military personnel 
include 66 cases of Q fever occurring in 1948 at an army recruit training camp in 
Switzerland (Spicer, 1978), an epidemic in Algeria involving 175 French soldiers (Spicer, 
1978), 78 cases of acute Q fever in British troops stationed in Cyprus between December 
1974 through June 1975 (associated with an epidemic of spontaneous abortions in goats 
and sheep) (Byrne, 1997), and 2 cases of Q fever during the Persian Gulf War (Byrne, 
1997).  In the documented Q fever epidemics involving the military, the loss of 
manpower in the involved units ranged from 23-77%, which could drastically affect unit 
 8
efficiency and mission readiness (Spicer, 1978).  While the significantly large outbreaks 
during World War II were probably caused by C. burnetii contaminated barns and 
bedding (Spicer, 1978), Q fever will continue to occur in military units due to the dust 
generated by the movement of heavy machinery and the worldwide distribution of C. 
burnetii.  
Sterilization/Disinfection 
 Historically, C. burnetii has been considered a difficult organism to eliminate.  
Many of the decontamination procedures used for other biological agents are 
unsuccessful in eliminating C. burnetii, presumably because of the small cell variant 
(SCV), small dense cell (SDC), and spore-like particle (SLP) forms (see C. burnetii 
Lifecycle Stages).  C. burnetii is also the second highest cause of laboratory infections.  
The SCV is susceptible to 70% ethanol, 5% chloroform, or 5% Micro-Chem Plus 
(National Chemical Laboratories, Philadelphia, PA) when applied for 30 minutes (Scott 
& Williams, 1990).  Soon after the discovery of C. burnetii in dairy herds and milk in 
Southern California, thermal inactivation studies were performed to modify existing 
pasteurization methods in order to inactivate the organism (Enright et al., 1957; Ransom 
& Huebner, 1951).  Based upon these studies, small volumes (1.0 ml) containing liquid 
suspensions of the organism are routinely inactivated by heating at 80oC for 1 hour to 
ensure laboratory safety when necessary.  Organisms distributed for use as antigens in 
serological applications are inactivated by exposure to cobalt (gamma) irradiation (Scott 
et al., 1989).  Humidified formaldehyde gas is effective if the contamination is contained 
within a room or an area that can be isolated and sealed (Scott & Williams, 1990).  
Filtration sterilization will not work due to the small size of the SCV form.  When 
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containing an accidental release, laboratory workers should use precautions such as 
HEPA filtered respirators and disposable garments to prevent inhalation.  It is extremely 
difficult to contain or disinfect an environmental contagion due to factors such as wind, 
the difficulty of isolating the contaminated area, and the absorption and cancellation of 
the disinfectant due to soil and extraneous materials at the contaminated site.   
C. burnetii Lifecycle Stages 
 C. burnetii has a complex life cycle involving at least two cell types (Figure 4); 
the spore-like small cell variant (SCV) and the metabolically active large cell variant 
(LCV) (McCaul & Williams, 1981; McCaul, 1991).  Two other variant forms, the small 
dense cells (SDC) and spore-like particle (SLP), are thought to exist, but their 
relationship to the SCV or the life cycle of the organism is poorly defined (Heinzen et al., 
1999; McCaul, 1991).  The SCV is 0.2 to 0.5 nm in diameter, rod-shaped, and is believed 
to be formed by asymmetrical division from its mother cell, the LCV, although the 
factors that induce differentiation are unknown (Heinzen et al., 1999; McCaul, 1991).  It 
has been speculated that either nutritional or pH variation in the host cell trigger the 
conversion, however there may be other signals that cause the differentiation that have 
not been identified (McCaul, 1991).  It has been shown that the Q fever agent can pass 
through 40 µm filters (Kordova, 1959); this is now attributed to the SCV, SDC, and SLP 
forms (Unpublished data, Williams).  The SCV is resistant to physical and chemical 
stress, such as elevated temperature, desiccation, osmotic shock, ultraviolet light, and 
chemical disinfectants (Malloch & Stoker, 1952; McCaul, 1991; Ransom & Huebner, 
1951; Scott & Williams, 1990).  The ability of the SCV to survive outside of a host cell 
can be attributed to the higher concentration of peptidoglycan (2.7-fold more than the 
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LCV) in its outer membrane (Amano et al., 1984; McCaul & Williams, 1981), appearing 
more dense than the LCV membrane with a smaller periplasmic space (McCaul, 1991).  
The organism protects its DNA in the SCV form by using histone-like proteins (Hq1 and 
ScvA) that bind to and condense the chromosomal DNA, giving the SCV a bulls-eye 
appearance very similar to the elementary body of C. trachomatis (Figure 4) (Heinzen & 
Hackstadt, 1996; Heinzen et al., 1996a).  SCV particles are introduced into the 
environment by infected animals shedding the organisms through urine, fecal matter, or 
parturition and birthing fluids.  Once the infectious matter has desiccated, the aerosolized 
particles can be inhaled by animals or humans, initiating infection (Tigertt et al., 1961).  
It is believed that the SCV is responsible for infections contracted from an environmental, 
rather than an animal, source. 
 The LCV is a gram-negative pleomorphic rod with a distinguishable outer 
membrane, periplasmic space, and inner membrane (McCaul, 1991).  The LCV differs 
from the SCV by its larger size [greater than 1 µm long, (Heinzen et al., 1999)], lack of 
ScvA protein (Heinzen et al., 1996a), appearance of a 29.5 kDa major outer membrane 
protein (McCaul et al., 1991a), the presence of protein translation factors (Seshadri et al., 
1999), susceptibility to harsh physical and chemical conditions, and a lower 
concentration of peptidoglycan in its outer membrane (Amano & Williams, 1984a; 
McCaul, 1991).  It is also the metabolically active cell form in in vitro acidic media 
experiments (pH 4.0-5.5) (Hackstadt & Williams, 1981b).  While the SCV form is 
generally linked to Q fever exposure in the environment, in the laboratory it has been 
observed that both the LCV and the SCV forms can invade host cells (Maurin & Raoult, 
1999; Wiebe et al., 1972). 
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Coxiella burnetii Genome 
 The Coxiella burnetii genome is defined by a single circular chromosome and, in 
all strains except the Scurry strain, a resident plasmid that is present in low copy numbers 
[perhaps 2-5 copies per cell] (Samuel et al., 1983; Seshadri et al., 2003).  The origin of 
replication of the circular chromosome was implied by the G-C skew of the chromosomal 
strands, and also by the location of dnaA, which encodes the DnaA protein for replication 
initiation (Seshadri et al., 2003).  In earlier work, carried out by an “origin search and 
rescue” technique employing strains of E. coli, an autonomous replication sequence (ars) 
was selected, isolated, and characterized (Suhan et al., 1994).  Although the ars supports 
the replication of recombinant plasmids in both E. coli and C. burnetii and contains 
several DnaA protein binding sites, no evidence was found to suggest that it functioned 
as an origin during C. burnetii growth in tissue cultures (Suhan et al., 1994; Suhan et al., 
1996).  The ars is located approximately 260 kilobase pairs from the designated origin. 
The C. burnetii Nine Mile strain genome consists of a chromosome of 1,995,275 
base pairs and a resident plasmid (QpH1) of 37,393 base pairs (Seshadri et al., 2003).  
Other C. burnetii strains have either QpH1 or different resident plasmids (QpRS, QpDG, 
QpDV, or integrated into the chromosome) (Lin & Mallavia, 1994; Minnick et al., 1990; 
Samuel et al., 1983; Samuel et al., 1985; Valkova & Kazar, 1995; Willems et al., 1999).  
A plasmidless strain (Scurry Q217), in which much of the plasmid information has been 
found inserted within the main chromosome, has also been characterized (Willems et al., 
1997).  The genome and QpH1 plasmid combined display 2,134 coding regions (possible 
genes), with 33.7% of these being hypothetical (Seshadri et al., 2003).  The chromosome 
also contains 29 insertion sequences, with 21 being the unique transposon IS1111 
 12
(Hoover et al., 1992; Seshadri et al., 2003).  All insertion sequences have greater than 
99% DNA identity, suggesting a recent introduction to the organism (Seshadri et al., 
2003).  No insertion sequences have been found in the plasmid (QpH1).  The Nine Mile 
strain genome has a G-C content of 42.6%, with a lower G-C content in the resident 
plasmid (39.3%) (Seshadri et al., 2003).   
Unlike free-living bacteria, C. burnetii has been able to survive the potentially 
lethal loss of some of its genes (by point mutations, deletions, or frame shifts) because it 
can transport compounds it cannot synthesize from its host cell [much like R. prowazekii] 
(Andersson et al., 1998; Hoover et al., 2002; Seshadri et al., 2003; Thompson et al., 
2003).  These 83 pseudogenes, while a significant number, represent a lower percentage 
of the total chromosome in C. burnetii than do pseudogenes of R. prowazekii (10.9% and 
~24%, respectively) (Andersson et al., 1998; Seshadri et al., 2003).  This difference in 
pseudogene number could mean that C. burnetii became an intracellular parasite at a later 
time than R. prowazekii.  C. burnetii has also shown a plasticity in its chromosome, with 
strains able to further modify their chromosome to form various avirulent phenotypes 
when grown in controlled laboratory conditions (see phase transition).   
Transformation studies 
 The ability to stably introduce foreign DNA or manipulate the C. burnetii 
chromosome has proven to be a difficult pursuit.  A step forward occurred when an 
autonomous replication sequence, a possible origin for C. burnetii DNA replication, was 
identified (Suhan et al., 1994).  This sequence was utilized as an origin in a plasmid 
containing an ampicillin resistance gene, and transformed into C. burnetii Nine Mile wild 
type organisms by electroporation, resulting in the first transformant of the organism 
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(Suhan et al., 1996).  Other research groups have transformed C. burnetii Nine Mile 
strain with a green fluorescence protein (Lukacova et al., 1999).  C. burnetii 
transformation experiments will remain difficult because of the limited antibiotics 
available for selection, due to the number of antibiotics reserved for treatment of chronic 
Q fever.  More work is required in this area before foreign DNA can be introduced 
reliably and remain stable in the organism. 
Lipopolysaccharide 
 The C. burnetii lipopolysaccharide (LPS) is a macromolecule in the outer 
membrane that protects the organism from the external environment, shields it from 
complement binding (Vishwanath & Hackstadt, 1988), and hides the charge of its outer 
membrane proteins and transporters (Hackstadt, 1990).  The C. burnetii LPS is composed 
of 74% hydrophilic and 26% hydrophobic regions, with unique Lipid A and outer antigen 
sugar components (Amano et al., 1987).  The C. burnetii Nine Mile wild type LPS is 
more than 1000 times less toxic to egg embryos and mice than the LPS of  either E. coli 
or S. typhimurium (Amano et al., 1987; Hackstadt et al., 1985).  The lipid A moiety of 
the C. burnetii LPS is highly conserved between strains examined (Toman et al., 2003; 
Toman et al., 2004).  The structure consists of a diphosphorylated D-glucosamine 
disaccharide backbone with four acyl fatty acid chains (Toman et al., 2004).  The acyl 
chain lengths vary in C. burnetii strains, and mass differences indicate a 
microheterogeneity of substitutions of fatty acids of different lengths in the lipid A 
(Toman et al., 2003; Toman et al., 2004).  Like other endotoxins, the lipid A has a non-
lamellar cubic aggregate structure that corresponds to a strictly conical shape of the lipid 
A moiety (Toman et al., 2004).  However, the inclination angle of the acyl chains to the 
 14
D-glucosamine disaccharide backbone is much less (around 40º) than for other 
enterobacteria (Toman et al., 2004). 
The inner core region of the C. burnetii LPS has been examined in detail by 
studying the Phase II variant LPS, and resembles other enterobacterial LPS molecules 
(Toman & Skultety, 1994).  This region is composed of D-mannose, D-glycero-D-
manno-heptose, and 3-deoxy-D-manno-2-octulosonic acid (Kdo) in a ratio of 2:2:3 
(Mayer et al., 1988; Toman & Skultety, 1994; Toman & Skultety, 1996).  The inner core 
attaches to the Lipid A region at a Kdo molecule, and the outer antigen region attaches at 
the outer core from  D-mannose and D-glycero-D-manno-heptose sugars (Toman & 
Skultety, 1996). 
 The outer antigen (O-antigen) region of the C. burnetii LPS is a complex structure 
of repeating components that is poorly defined.  Molecules such as D-mannose, 
galactosaminuronic acid, glucosamine, L-rhamnose, 6-deoxy-3-C-methyl-D-gulose 
(virenose), 3-C-(hydroxymethyl)-L-lyxose (dihydo-hydroxystreptose) and other unknown 
components constitute the branches of the O-antigen region, but the exact sequence of the 
structure is unknown (Mayer et al., 1988; Toman & Kazar, 1991; Toman et al., 1998).  
Virenose and dihydro-hydroxystreptose are rare sugars that have not been observed in 
other bacterial lipopolysaccharides, and their closest related sugars are found in 
antibiotics [virenomycin and hydroxy-streptomycin, respectively] (Mayer et al., 1988).  
This information is interesting because it may, when taken with the facts that (i) nearly 
one-quarter of the transport genes found in C. burnetii are drug efflux systems, and (ii) 
there are pseudogenes with homology to antimicrobial lantibiotics and β-lactamases 
(Seshadri et al., 2003), suggest that C. burnetii was originally a free-living acidophilic 
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organism competing with other bacteria in the environment.  It is suggested, due to phase 
transition studies of Nine Mile RSA514, that virenose and dihydro-hydroxystreptose are 
terminal sugars (Amano et al., 1987; Mayer et al., 1988).  The O-antigen region is 
important to protect C. burnetii from compliment-mediated killing, due to the fact that 
only the avirulent Phase II organism is susceptible to complement (Vishwanath & 
Hackstadt, 1988).  A complete LPS is also considered one of the molecules important for 
immunity to C. burnetii, because vaccinating with Phase II whole-cell vaccines does not 
confer lasting immunity (Ormsbee et al., 1964). 
 Most of the genes for LPS synthesis, including synthesis of the outer repeating 
units of the O-antigen and the LPS inner core, are clustered into two regions of the 
genome (Seshadri et al., 2003).  These gene clusters also include large numbers of genes 
related to nucleotide sugar metabolism involved in the polymerization of the sugar 
branches in the O-antigen (Seshadri et al., 2003).  Unlike the rest of the LPS biosynthesis 
genes, the genes for the synthesis of Lipid A and Kdo components of the LPS are 
scattered throughout the genome (Seshadri et al., 2003).   
Phase Transition 
 Antigenic phase transition in C. burnetii was first reported by Stoker and Fiset, 
who showed that reactivity to early guinea pig antisera changed with passage history in 
embryonated eggs (Stoker & Fiset, 1956).  When virulent wild type C. burnetii (Phase I) 
strains are passaged for many replication cycles in either embryonated eggs or tissue 
culture systems, the organisms will undergo a permanent phase transition into avirulent 
variants (Phase II) (Amano & Williams, 1984b; Hoover et al., 2002; Vodkin & Williams, 
1986; Williams et al., 1981).  Our knowledge of the events of phase transition from a 
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wild-type C. burnetii to an avirulent variant is limited.  In many strains of C. burnetii 
(Australian, M44 Grita, Priscilla, and Nine Mile) an avirulent phase variant with an LPS 
truncation occurs, but the genetic modifications which underlie phase transition are not 
uniform (Thompson et al., 2003).  In the Nine Mile strain, two types of chromosomal 
deletions have been characterized from purified isolates.  The Nine Mile Phase II clone 4 
organisms have a chromosomal deletion [roughly 26 kilobase pair region that consists 
primarily of O-antigen synthesis genes (Hoover et al., 2002)], exhibit a more severely 
truncated LPS that lack both rare sugars [virenose and dihydrohydroxystreptose 
(Schramek et al., 1985)], and are avirulent (Amano & Williams, 1984b; Amano et al., 
1987; Stoker & Fiset, 1956; Vishwanath & Hackstadt, 1988).  Despite the chromosomal 
deletion and modification, the Phase II organism is still able to form an SCV cell form 
(unpublished data, Heinzen & Shaw).  The Nine Mile RSA514 variant displays a larger 
chromosomal deletion (31.6 kb) in the same region as the Phase II deletion, possesses an 
intermediate LPS, and is partially virulent (Hoover et al., 2002; Moos & Hackstadt, 1987; 
Vodkin & Williams, 1986).  The varied phenotypes from the Nine Mile phase variants 
suggest that Phase II organisms may have other chromosomal deletions or mutations 
which have not been characterized, yet play a role in loss of the complete wild type 
phenotype.  It is also unknown if the Nine Mile phase transition is consistent, causing the 
same chromosomal mutations each time a laboratory-passed C. burnetii organism adapts.  
Phase transition in the Priscilla strain occurs by undergoing a loss of LPS sugars in three 
stages, eventually leading to a truncated LPS (Ftacek et al., 2000), however there is no 
genetic information available on the avirulent phenotype.  Little information is available 
on M44 or Australian Phase II strain (QD), variants that also display the truncated LPS 
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phenotype and are avirulent (Vodkin et al., 1986; Williams et al., 1986).  PCR analysis 
has determined that both M44 and Australian Phase II variants retain many of the genes 
lost in the deletion of Nine Mile strain Phase II organisms, but the fidelity of these genes 
is unknown (Thompson et al., 2003).   
 The events of phase transition not only affect the phenotype and genome of the 
affected organism, but in the Nine Mile strain it appears to alter the invasion of host cells. 
Phase II organisms can invade host cells faster, and are more successful at establishing 
persistent infections in lab cell lines than Phase I organisms (Baca et al., 1981; Baca & 
Paretsky, 1983).  C. burnetii Nine Mile Phase II invasion studies suggest that the uptake 
process is mediated by both the leukocyte response integrin, αvβ3 (LRI), and CR3 (Capo 
et al., 1999).  This is in agreement with earlier observations that showed that complement 
components (such as C3) can attach to and kill Phase II organisms (Vishwanath & 
Hackstadt, 1988).  Once the Phase II organism has attached to the host cell the membrane 
does not visibly ruffle and the organism cannot delay lysosome fusion to its endosome 
compartment (Howe & Mallavia, 2000; Meconi et al., 1998), suggesting that the Phase II 
organism lacks a factor to modify the behavior of the host cell.  The final vesicle of the C. 
burnetii Phase II organism has characteristics of a mature phagolysosome, including the 
marker proteins Rab5, Rab7, and LAMP-1 (Beron et al., 2002; Heinzen et al., 1996b; 
Lem et al., 1999), but it is unknown if the wild type C. burnetii phagosome is different 
from the Phase II phagosome.  Due to the differences in invasion and survival between 
the wild type and the phase variant C. burnetii organisms (see Invasion of Host Cells), we 
cannot assume that the organisms react or modify the host cell in an identical manner.  
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The phase transition event(s) also seem to modify the replication of Nine Mile 
strain organisms in certain growth systems; Phase II organisms grown in embryonated 
eggs display consistently lower yields when compared to Phase I organisms (Miller & 
Thompson, 2002; Waag et al., 1991).  In some growth experiments using Baby Hamster 
Kidney (BHK-21) cells (Miller et al., 2004), we have observed the number of 
intracellular Phase I organisms to be higher than that of Phase II organisms cultured in 
identical conditions.  This growth can be significantly improved with the addition of 
cytidine to the tissue culture media, but the reason for this improvement is unknown at 
this time.  Due to our poor understanding of the phase transition and the genetic 
modifications the chromosome undergoes, it is probable that other modifications exist 
that are relieved by cytidine or a cytidine product, allowing for the increased Phase II 
growth.   
Invasion of Host Cells 
 The C. burnetii bacterium has an advantage in that, once it has contaminated an 
environment, it can infect an animal or person with an extremely low infectious dose (1-
10 organisms, (Tigertt et al., 1961).  Once the C. burnetii organism has been introduced 
into the host, either by inhalation, consumption, or other route, the organism can bind to 
and invade a host cell.  In lab studies, C. burnetii has exhibited an ability to infect a wide 
variety of cell lines, including but not limited to: human monocyte cells (THP-1), 
fibroblast cells, Vero cells, chick endodermal (primary culture) cells, Chinese Hamster 
Ovary (CHO) cells, baby hamster kidney (BHK-21) cells, and mouse macrophage cell 
lines (Baca et al., 1981; Burton et al., 1978; Hackstadt & Williams, 1981b; Khavkin et 
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al., 1981; Maurin & Raoult, 1999; Meconi et al., 1998; Schneider, 1989; Veras et al., 
1995; Zuerner & Thompson, 1983). 
Wild type C. burnetii (Phase I) organisms are thought to initiate infection of host 
cells by binding to leukocyte response integrin αvβ3 (LRI) and integrin-associated protein 
(IAP) complex while not engaging the CR3 (Capo et al., 1999; Mege et al., 1997).  
During the attachment and invasion process, wild type organisms induce activation of 
Protein Tyrosine Kinases (PTK) and tyrosine phosphorylation of several substrates 
thought to interfere with cytoskeleton organization, causing the host cell surface to ruffle 
and change morphology (Meconi et al., 1998; Meconi et al., 2001).  The C. burnetii 
genome also contains 13 ankyrin repeat-containing proteins that could mediate 
interaction of the plasmid membrane with the membrane skeleton, aiding the invasion 
process (Batrukova et al., 2000; Seshadri et al., 2003).  Other genes, such as homologues 
of the L. pneumophila EnhA, EnhB, and EnhC may be involved in cell entry, but their 
role in C. burnetii invasion needs to be investigated (Seshadri et al., 2003).  The 
organism is then internalized and shuttled through an endosomal pathway, where vacuole 
ATPases lower the pH to 5.5 (Howe & Mallavia, 2000).  In laboratory experiments, the 
organism has been shown to transport amino acids in acidified media, however it is 
unknown at what stage in the invasion process the organism becomes fully active [able to 
replicate DNA and synthesize proteins] (Howe & Mallavia, 2000).  It has also been 
shown to transport guanosine at neutral pH, but the reason for this ability is unknown 
(Miller & Thompson, 2002).  In J774A.1 mouse macrophage cells, wild type C. burnetii 
can delay the binding of lysosomes to its vesicle (Howe & Mallavia, 2000); however it is 
unknown if this event occurs in other cell lines.  We also do not know how the organism 
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modifies its vesicle to promote survival and replication.  Current research is focusing on 
the signaling mechanisms used by C. burnetii to influence the host cell. 
Once C. burnetii has begun replication within the acidified phagosome, it has a 
replication time of between 12-20 hours (Zamboni et al., 2001).  The organism has only 
one rRNA operon, which is consistent with organisms that have a slow growth rate 
(Afseth et al., 1995).  This slow growth adaptation may have evolved to allow for the 
accumulation of the maximum bacterial load in a host cell, while gaining as much 
metabolic precursors from the host as possible before host cell lysis.  This would allow 
for the greatest number of C. burnetii organisms in the blood, increasing the opportunity 
for the organisms to find new host cells and continue the cycle.  This is thought to be the 
reason for slow growth in other intracellular parasites as well, such as R. prowazekii 
(Winkler, 1995).  In the growth compartment, both LCV and SCV forms are present 
(McCaul et al., 1991b), perhaps ensuring survival for the organism once the host cell is 
lysed.  C. burnetii organisms are thought to kill their host cells by replicating within the 
acidified phagosome compartment, enlarging the vacuole until it exerts enough internal 
pressure to lyse the host, thereby releasing the organisms.   
Environment of Acidified Phagosome 
Once the organism has established itself in the acidified phagosome, C. burnetii 
has to survive a harsh environment designed to destroy pathogens.  In recent years, our 
understanding of the phagolysosome compartment has improved, but it is still 
incomplete.  The membrane of a mature phagosome is a complex organelle composed of 
over 600 different proteins, some of which are unidentified (Desjardins, 2003; Garin et 
al., 2001).  Some of these proteins are H+-translocating ATPases, which lower the pH of 
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the compartment.  The C. burnetii organism has adapted to the acidic pH and apparently 
can only replicate in this environment.  Attempts to reproduce the conditions required for 
replication by axenic media have failed, showing that more than an acidic environment, 
glucose, and a supplement of 20 amino acids and thymidine are required for replication 
(Chen et al., 1990; Hackstadt & Williams, 1981b; Thompson, 1991).  The organism has 
also adapted by having a much higher percentage of basic proteins when compared to 
other bacteria.  This may be an adaptation enabling the organism to titrate or regulate the 
H+ ions, along with its predicted sodium ion/proton exchangers, from its cytoplasm if it is 
unable to maintain its adenylate energy charge for cytoplasmic pH maintenance (Seshadri 
et al., 2003).  
It is unknown at this time how closely a mature phagolysosome resembles the 
acidified phagosome containing C. burnetii organisms.  While C. burnetii occupies this 
acidified phagosome, it grows until it becomes the largest compartment in the host cell, 
dwarfing and pushing aside the cell nucleus (McCaul, 1991).  This may be caused by the 
host cell fusing lysosomes and possibly endosomes to the C. burnetii phagosome in an 
effort to eliminate the organism.  Conversely, the growth of the acidified phagosome 
compartment may be due to the organism somehow controlling the host cell and some of 
its functions.  Within the compartment of a normal phagolysosome are a number of 
enzymes delivered by lysosomes used to digest pathogens into peptides for MHC 
presentation, as well as digesting DNA and protein material to nucleoside and amino 
acids for use by the cell.   It is assumed that these enzymes are also present in the C. 
burnetii acidified phagosome.  The cell also uses nitric oxide and oxygen radicals (Howe 
et al., 2002), as well as cytokines such as TNF-α and IFN-γ, to induce cytotoxic or cell-
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mediated responses and clear the infection.  C. burnetii is thought to protect itself from 
oxygen radicals and oxidative bursts within its compartment by using acid phosphatase, 
catalase, and superoxide dismutase (SOD) enzymes (Baca et al., 1993; Baca et al., 1994; 
Li et al., 1996; Samuel et al., 2003).  C. burnetii has been observed during in vitro acid 
activation experiments to release a number of unidentified proteins into the media (Redd 
& Thompson, 1995).  The organism also, at acidic pH, may use a secretion system 
(possibly Type I, II, or IV) to secrete a number of proteins into the environment (Seshadri 
et al., 2003; Zamboni et al., 2003).  At this time we are unsure of what specific proteins 
C. burnetii secretes, or what effect these proteins have on the host cell. 
 Despite the challenge the mature acidified phagosome poses to the organism and 
its survival, the compartment is also presumed to be rich in metabolic precursors the 
organism requires for metabolism and replication.  It is known that phagolysosomes 
contain a large quantity of useful nutrients, including nucleosides, amino acids, 
phosphates, glucose, sulfates, and phosphates (Pisoni & Thoene, 1991; Thompson, 1988).  
If these components are also available in the C. burnetii acidified phagosome, this wealth 
of resources would enable the parasite to become more energy efficient by discarding or 
inactivating portions of its genes.   
Metabolic Pathways 
Despite the elimination of 83 genes, sequence evidence suggests C. burnetii has 
maintained most of its metabolic capabilities, and retains the genes for glycolysis, the 
Entner-Doudoroff pathway, the electron transport chain, the Embden-Meyerhof-Parnas 
pathway, gluconeogenesis, the pentose phosphate pathway, and the tricarboxylic acid 
(TCA) cycle (Seshadri et al., 2003).  It also appears to have complete pathways for 
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purines and pyrimidines, fatty acids, phospholipids, and cofactors (Seshadri et al., 2003).  
The sequence also suggests that C. burnetii can utilize glucose, xylose, galactose, and 
glycerol (Seshadri et al., 2003).  The chromosome is missing the glyceraldehydes-3-
phosphate (GAP) pyruvate pathway for IPP synthesis, as well as being auxotrophic for 11 
amino acids [including leucine, isoleucine, phenylalanine, tryptophan, valine, histidine, 
lysine (Seshadri et al., 2003)].   
Transport 
 Even though C. burnetii has many complete biochemical pathways for 
macromolecule synthesis, it also appears to transport many components such as amino 
acids, sugars, and nucleosides; probably to conserve energy and its adenylate charge for 
other requirements.  The genome sequence suggests it has two sugar transporters (xylose 
and glucose), 3 peptide transporters, and 15 amino acid transporters (Seshadri et al., 
2003).  It has four predicted sodium ion/proton exchangers, presumably for maintenance 
of the cytoplasmic pH (Seshadri et al., 2003).  The genome also contains a number of 
sequences that share homology with various types of ABC (ATP binding cassette) 
transport proteins (Seshadri et al., 2003).  The genome sequence predicts that three 
mechanosensitive ion channels and three osmoprotectant transporters exist (Seshadri et 
al., 2003).  More than a quarter of the predicted transporters are predicted to be drug-
efflux pumps, which may play a role in the protection from phagosome antimicrobial 
defensin proteins or resistance to antibiotics (Seshadri et al., 2003).  There is also a 
putative multidrug transporter protein found in a potential “pathogenicity island” flanked 
by insertion sequences (Seshadri et al., 2003).  There is no evidence, in the sequence or in 
biochemistry experiments, for an ATP/ADP exchanger to scavenge ATP from its host 
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(Miller & Thompson, 2002; Seshadri et al., 2003), as is used by R. prowazekii or C. 
trachomatis (Tjaden et al., 1999; Winkler, 1976).  This lack of an ATP/ADP exchanger 
makes sense due to the rarity of ATP within the environment of an acidified phagosome 
(Pisoni & Thoene, 1991). 
 Genome analysis has also suggested homology with Type I, II and IV secretion 
systems (Seshadri et al., 2003).  The proposed type IV secretion system, which has many 
similarities to the L. pneumophila icm-dot genes (Segal et al., 1999; Sexton & Vogel, 
2002; Zusman et al., 2003), has components that can complement function with similar 
genes in L. pneumophila [dotB, icmS, icmT, and icmW (Zamboni et al., 2003; Zusman et 
al., 2003)].  This system may play a role in the subjugation of the host cell; however 
more research into its function and the components that may be released by the secretion 
apparatus must be performed before any conclusion can be reached. 
 Much of our current knowledge of C. burnetii transport comes from research 
using acidified media.  First developed in the early 1980’s by Hackstadt and Williams 
(Hackstadt & Williams, 1981b), it was found that a simple media at pH 4.0-5.5 would 
allow DNA and protein synthesis to occur so long as an energy source (glutamate) was 
available (Hackstadt & Williams, 1981c).  This media is incomplete in that it will not 
support replication of the organism.  The lack of organism replication in the acidified 
media could be caused by either the loss of a signal pathway between the host cell and 
the organism, or by one or a number of metabolites that are not available in the media.  
Using the acidified media, information on glucose and glutamate transport and usage, as 
well as amino acid transport has been obtained (Chen et al., 1990; Hackstadt & Williams, 
1981c; Hendrix & Mallavia, 1984; Zuerner & Thompson, 1983).  DNA synthesis also 
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occurs in the acidified medium, but evidence suggests that new chromosome initiations 
may not form during in vitro acid activation (Chen et al., 1990).  Inclusion of a complete 
amino acid supplement in the acidified media resulted in a large increase in protein 
production (Chen et al., 1990; Zuerner & Thompson, 1983), a fact that can now be 
appreciated since it is known from genome studies that the organism must be auxotrophic 
for 11 amino acids (Seshadri et al., 2003).  It has also been shown that C. burnetii will 
secrete proteins in the acidified media, although these proteins have not yet been 
identified (Redd & Thompson, 1995).   
Intracellular bacteria purine and pyrimidine transport systems 
 Despite the difficulties in studying transport in obligate intracellular organisms, 
some progress has been made to define their purine and pyrimidine transport capabilities.  
Rickettsia prowazekii, which lives in the cytoplasm of its host cell, has a transporter 
protein that transports nucleotide monophosphates (AMP, UMP, GMP) (Tjaden et al., 
1999; Winkler et al., 1999).  The organism has also been shown to be auxotrophic for 
these purine and pyrimidine compounds.  R. prowazekii does not transport CMP, but 
relies on the conversion of UTP to CTP to synthesize its required cytidine (Winkler et al., 
1999).  It is also an energy parasite, utilizing an ADP/ATP translocase protein to 
exchange ADP with the higher energy ATP of the host cell (Winkler, 1976).  Chlamydia 
trachomatis, which replicates in a non-acidified parasitophorous vacuole, has been shown 
to transport nucleotide triphosphates (ATP, GTP, UTP, CTP) (McClarty & Tipples, 1991; 
Tipples & McClarty, 1993).  While C. trachomatis has been found auxotrophic for three 
of the four nucleotide triphosphates, it uses the CTP synthase enzyme to convert UTP to 
CTP to synthesize cytidine (Tipples & McClarty, 1993).  Like R. prowazekii, Chlamydia 
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sp. are energy parasites that use an ADP/ATP translocase to maintain their adenylate 
charge (Tjaden et al., 1999).  In these intracellular bacteria, no methods of synthesizing 
cytidine have been identified or described other than transport or CTP synthase activity.   
 C. burnetii is most closely related genetically to Legionella pneumophila and 
resides in the same phylogenetic order, however Legionella sp. are not true obligate 
intracellular parasites.  While Legionella organisms invade and replicate in non-acidified 
parasitophorous vacuoles, the organisms are capable of cell-free growth on plates 
supplemented with iron (Reeves et al., 1981; Warren & Miller, 1979).  Research has 
suggested that Legionella sp. can transport and display improved growth rates in the 
presence of the nucleobase guanine, and seems to have the capability to transport other 
nucleobases (Pine et al., 1986). 
Pyrimidine de novo biosynthesis 
 In many bacteria, pyrimidine synthesis of cytidine, uridine, and thymidine is a 
highly conserved process (Figure 5).  The pathway begins with carbamoyl phosphate 
synthesized from HCO3-, glutamine, and ATP by the carbamoyl phosphate synthetase 
(Holden et al., 1999; White, 1995).  Next, in a highly regulated step, the carbamoyl 
phosphate is transferred to aspartate by aspartate transcarbamoylase, forming N-
carbamoylaspartate (Hoover & Williams, 1990; White, 1995).  Aspartate 
transcarbamoylase is regulated by feedback inhibition of the ultimate product, CTP 
(White, 1995).  Water is removed from the compound by the enzyme dihydroorotase 
(Lehninger et al., 1993).  This step closes the pyrimidine ring, forming L-dihydroorotate.  
The compound is oxidized to form orotate (Lehninger et al., 1993; White, 1995).  Once 
orotate has been synthesized, a ribose-5-phosphate side chain, provided by 
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phosphoribosyl pyrophosphate (PRPP), is attached to the compound by displacing the PPi 
group on PRPP to form orotidine 5'-phosphate (orotidylate) (White, 1995).  Orotidylate is 
decarboxylated to form uridine 5'-monophosphate (UMP) (White, 1995).  UMP is 
phosphorylated utilizing ATP as a phosphate donor to form UDP and UTP (White, 1995).  
Once UTP has been synthesized, the CTP synthase enzyme can convert the compound to 
cytidine 5'-triphosphate (Lieberman, 1956).  
  In some obligate intracellular bacteria, such as Rickettsia prowazekii, mutation or 
deletion has eliminated some of the pyrimidine biosynthesis enzymes because some 
precursors can be obtained from the host cell (Winkler et al., 1999).  The genetic 
sequence of C. burnetii Nine Mile suggests it has a complete and functional pyrimidine 
biosynthesis pathway (Seshadri et al., 2003). 
CTP synthase 
Studies in both prokaryotes and eukaryotes have shown that CTP synthase is a 
large (~210 kDa) allosteric homotetrameric enzyme with four identical active sites 
(Levitzki et al., 1971; Levitzki & Koshland, 1972; Long et al., 1970).  Experiments using 
prokaryotic CTP synthases, including Escherichia coli CTP synthase, have shown that 
the enzyme is influenced by both positive and negative cooperativity in substrate binding 
(Levitzki & Koshland, 1969; Long & Pardee, 1967).  Eukaryote CTP synthase from 
Ehrlich ascites tumor cells or liver cells is influenced less by cooperativity than is the 
bacterial enzyme (Kizaki et al., 1981; Savage & Weinfeld, 1970).  Sedimentation 
equilibrium techniques have been used to show that native E. coli enzyme equilibrates 
between the monomer, dimer, and tetramer forms (Robertson, 1995).  When ATP and 
UTP are available at saturatable concentrations, this enzyme will shift toward the 
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tetramer form (Anderson, 1983; Pappas et al., 1998).  The enzyme amidates a uridine 
triphosphate (UTP) to convert it to cytidine triphosphate (CTP) by utilizing adenosine 
triphosphate (ATP) to phosphorylate the UTP molecule (Levitzki & Koshland, 1971; von 
der Saal et al., 1985).  Glutamine is a nitrogen donor (Chakraborty & Hurlbert, 1961), 
and glutamine triphosphate (GTP) initiates allosteric activation (Robertson, 1995) and 
stabilizes the intermediate form of the molecule (Bearne et al., 2001).  In E. coli, it has 
been shown that GTP is a positive allosteric effector that increases the enzyme efficiency 
of glutamine-dependent CTP synthesis 45-fold (Iyengar & Bearne, 2003).  Magnesium is 
required in the active site for enzyme function (Kizaki et al., 1981; Lieberman, 1956; 
Robertson & Villafranca, 1993).  Each monomer contains a glutamine amide transfer 
domain (Weng et al., 1986), which catalyses the conversion of glutamine to glutamate 
and NH3 during the reaction (Robertson, 1995).  The E. coli CTP synthase enzyme will 
display variable Hill coefficients depending on the concentration of the available 
substrates (Levitzki & Koshland, 1969; Long & Pardee, 1967) [for example, a UTP Hill 
plot in the presence of saturating concentrations of ATP (0.65 mM) give a value of 1.3, 
while lowering the concentration of ATP to non-saturating conditions (0.2 mM) will give 
a Hill value of 2.8] (Long & Pardee, 1967).  The positive and negative cooperativity in 
the bacterial enzyme can cause each subunit to have subtle conformational differences 
that result in each subunit of the homotetramer having differences in substrate affinity 
(Levitzki & Koshland, 1969; Long et al., 1970).   
Overview of Project 
 In bacteria, cytidine is a vital component of many macromolecules required for 
replication and survival.  It is one of the building blocks of DNA and RNA.  It also plays 
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a role in most bacteria in lipopolysaccharide biosynthesis, not only for the construction of 
2-keto-3-deoxyoctulosonic acid (Kdo) (Raetz, 1990), but also in the nucleotide sugars 
produced for some of the repeating sequence of the LPS outer antigen (Raetz, 1990).  The 
C. burnetii Nine Mile strain genome contains many genes for the synthesis of nucleotide 
sugars involved in LPS biosynthesis (Seshadri et al., 2003).  Cytidine also plays a role in 
the regulation of gene transcription and translation by turning off the CytR repression 
system in E. coli and S. typhimurium (Gavigan et al., 1999; Thomsen et al., 1999), 
although loci with reasonable identity (30%) to CytR in E. coli has been found in C. 
burnetii; their function has yet to be verified.  Preliminary growth data in the BHK-21 
cell line suggested that extracellular cytidine “rescued” avirulent Phase II organisms from 
stagnant growth and improved replication.  Phase I organisms grew equally well in any 
growth condition in BHK-21 fibroblasts.   
The Phase II variant, as discussed earlier, is generated by genetic modifications 
that consist of a chromosomal deletion (Hoover et al., 2002), and may include other 
smaller deletions and mutations, that result in an organism analogous to deep rough 
mutants observed in S. typhimurium (Brandenburg et al., 1992; Schramek & Mayer, 
1982).  The chromosome deletion, a 26-kilobase pair section (Hoover et al., 2002; 
Vodkin & Williams, 1986), contributes to a severely truncated lipopolysaccharide that 
has lost all of the outer antigen moieties, leaving the inner core and lipid A regions of the 
molecule (Amano et al., 1987; Toman et al., 2004).  Other chromosomal deletions or 
mutations probably contribute to the avirulent phenotype, but they have not been 
observed due to their small size (Vodkin & Williams, 1986).   
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Genetic modification of the Phase II organism by phase transition may also 
interrupt metabolite pathways.  The biochemical pathways would be disrupted when the 
host cell provides ample concentrations of the metabolite.  Purine and pyrimidine 
biosynthesis pathways have been interrupted in other intracellular bacteria [such as R. 
prowazekii and C. trachomatis; (Andersson et al., 1998; Stephens et al., 1998)].  It is 
possible that the phase transition event(s) may further modify the chromosome to modify 
and inhibit genes other than those in the 26-kb deletion.  The most obvious and testable 
explanation to the improved Phase II growth in the presence of cytidine was that part of 
the Phase II pyrimidine biosynthesis pathway was inhibited or disrupted.  We focused on 
the C. burnetii CTP synthase, the single enzyme responsible for de novo cytidine 
synthesis via the conversion of uridine triphosphate to cytidine triphosphate.  The 
hypothesis for this project is that the C. burnetii Nine Mile Phase II CTP synthase 
enzyme is inactive, either by deletion, genetic mutation, or enzymatic inhibition.  
This enzyme deficiency is overcome by the transport or diffusion of extracellular 
cytidine (Figure 5), allowing the Phase II organism to behave more like the Phase I 
wild type organism.  To test the hypothesis, three specific aims were developed: (1) 
Growth experiments were performed to determine if cytidine only affects Phase II 
organism growth in BHK-21 cells.  Three dimensional landscape graphs were used to 
analyze the effect growth conditions had on intracellular replication.  The growth study 
quantified the effect of extracellular cytidine on Phase I and Phase II organisms, as well 
as being the first description of an early C. burnetii infection of fibroblast cells.  (2) 
Transport and incorporation of radiolabeled nucleosides, nucleotides, and nucleobases for 
Phase I and Phase II organisms were examined to determine if the organism could 
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incorporate extracellular cytidine into macromolecules.  The purine and pyrimidine 
transport systems in C. burnetii were observed using concentration assays to determine if 
nucleoside transport is an active or passive process.  (3) The CTP synthase genes and 
resultant enzymes for C. burnetii Nine Mile Phase I and Phase II organisms were 
compared.  This examination would identify if an inactive Phase II CTP synthase is the 
cause for the improved Phase II growth in BHK-21 fibroblasts in the presence of 
cytidine.  These specific aims will be discussed in detail in the following chapters.
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Figure 1:  C. burnetii in acidified phagosome of RK-13 host cell.  C. burnetii Nine 
Mile strain organisms in acidified phagosomes are visualized using FITC-labeled 
antibody.  Host cell actin is labeled using Texas red-labeled phalloidin (picture courtesy 
of Ed Shaw). 
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Figure 2:  Transmission cycle of C. burnetii.  Potential mechanisms of human infection 
by C. burnetii are diagramed.  Heavy black arrows signify major infection pathways, and 
thin gray arrows represent minor infection pathways.  Humans are considered a dead-end 
host, and human-to-human infections are very rare.
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Figure 3: IFA of C. burnetii in 1% Yolk Sac.  C. burnetii homogenized yolk sac was 
diluted to 1% in PBS pH 7.4 and spotted onto microscope slides.  The slides were 
acetone-fixed, treated with human primary antibody and goat α-human FITC-labeled 
secondary antibody, and examined under 400 (a) and 1000 (b) magnification using a UV 
light source.  
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Figure 4:  C. burnetii Nine Mile organisms in an acidified phagosome within L929 
cells.  Tissue culture cells were chronically infected, fixed with gluteraldehyde, 
embedded in paraffin, and visualized using scanning electron microscopy.  Large cell 
variants (LCV) and small cell variants (SCV) are identified by arrow (picture courtesy of 
Ed Shaw). 
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Figure 5: Pyrimidine biosynthesis pathway.  Pathways and enzymes used to construct 
pyrimidine nucleosides, nucleotides, and nucleobases in bacteria.  Arrows show direction 
of synthesis (Lehninger et al., 1993). 
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Abstract 
Coxiella burnetii, a slow-growing, gram-negative, obligate intracellular 
bacterium, is the causative agent of Q fever in humans.  The avirulent Phase II C. burnetii 
Nine Mile strain can invade and establish persistent infections in a wide variety of 
laboratory cell lines, and is generally considered to be easier to grow in culture than the 
wild-type Phase I organism.  Efforts to improve Phase I organism yield in the BHK-21 
cell line demonstrated that high CO2 conditions and the use of Dulbecco’s Modified 
Eagle Medium (D-MEM) with 4.5g/L glucose supplementation resulted in higher 
organism yields.  Phase II organisms grown in the same cell line and conditions showed 
lower growth rates.   Analysis revealed that increased average numbers of C. burnetii 
Phase I organisms within fibroblasts was due to higher growth rates within the hosts 
rather than to increased uptake or to increased cell-to-cell spreading.  Addition of the 
nucleoside cytidine to the growth medium stimulated growth of Phase II but not Phase I 
organisms.    
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Introduction 
Coxiella burnetii is an obligate intracellular parasite that grows slowly within 
acidified phagosomes, with a generation time of 12-20 hours (Zamboni et al., 2001).  The 
organism can infect a broad range of animals, including humans, and is the causative 
agent of Q fever.  Q fever usually is an acute disease, but in rare cases, persistent 
infection can result in more significant illnesses, such as chronic Q fever endocarditis 
(Maurin & Raoult, 1999).  Post-Q fever fatigue syndrome has also been reported (Harris 
et al., 2000; Maurin & Raoult, 1999).  The C. burnetii Nine Mile wild-type (Phase I clone 
7) strain can undergo phase transition (Stoker & Fiset, 1956), which results in a severe 
truncation of the lipopolysaccharide (LPS) molecules and a subsequent loss of virulence 
(Vishwanath & Hackstadt, 1988).  The resulting avirulent Phase II (clone 4) organism has 
a 26-kb pair DNA deletion that spans one LPS biosynthetic region of the chromosome 
(Hoover et al., 2002; Vodkin & Williams, 1986).  It is not known whether this deletion 
explains all of the phenotypic differences between Phase I and II organisms (Hoover et 
al., 2002; Thompson et al., 2003).   
C. burnetii organisms  infect a wide variety of host cells in vitro, including  
human monocytes (THP-1 cells), rodent fibroblasts (L-929 and BHK-21 cells), Vero 
cells, chick endodermal (primary culture) cells, Chinese hamster ovary cells, and several 
mouse macrophage cell lines (Baca et al., 1981; Hackstadt & Williams, 1981b; Maurin & 
Raoult, 1999; Zuerner & Thompson, 1983).  In most cell lines that have been used for 
study, Phase II organisms invade host cells faster than Phase I organisms and are more 
successful at establishing persistent infections (Baca et al., 1981).  In earlier work, C3 
was found to bind to Phase II but not Phase I organisms (Vishwanath & Hackstadt, 
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1988).  In more recent work, Phase II uptake was found to be mediated by leukocyte 
response integrin, αvβ3 (LRI), and CR3 (Capo et al., 1999; Vishwanath & Hackstadt, 
1988).  Phase I organisms bind to and invade host cells by using the αvβ3 (LRI) and 
integrin-associated protein complex, while not engaging CR3 (Capo et al., 1999; Mege et 
al., 1997; Vishwanath & Hackstadt, 1988).  During attachment and invasion, Phase I 
organisms induce activation of protein tyrosine kinases and tyrosine phosphorylation of 
several substrates thought to interfere with cytoskeleton organization, causing the host 
cell to change morphology (Meconi et al., 1998; Meconi et al., 2001).  Differences in the 
invasion process may explain why, under conventional culture conditions, Phase II 
organisms establish infection in host cells faster than do Phase I organisms.  However, in 
embryonated eggs, the growth yield of Nine Mile Phase I organisms is consistently better 
than that for Phase II organisms (Miller & Thompson, 2002; Waag et al., 1991).   
Once C. burnetii organisms have entered the host cell and are established in an 
acidified phagosome, they are presumably positioned to take advantage of the 
concentrations of nucleosides, amino acids, and other metabolic precursor molecules 
available within that subcellular niche (Pisoni & Thoene, 1991).  Past researchers in our 
laboratory have used amino acid and nucleoside supplementation to improve metabolic 
activity in vitro (Chen et al., 1990; Zuerner & Thompson, 1983).  They also used higher 
concentrations of CO2 and glucose to increase yields of C. burnetii Phase I organisms 
grown in BHK-21 cells (Zuerner & Thompson, 1983).  We have previously determined 
that nucleosides but not nucleotides are transported by C. burnetii organisms and 
incorporated into macromolecules (Miller & Thompson, 2002).  In the present work, we 
sought to improve the growth of Phase II organisms in BHK-21 cells by using nucleoside 
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supplements.  We used cell staining and direct enumeration techniques to determine the 
number of bacteria within individual BHK-21 cells.  For the first time, we demonstrate 
the distribution of C. burnetii Phase I and Phase II organisms early in the infection 
process.  Inclusion of cytidine in the host cell growth medium improved the net number 
of Phase II organisms 3-fold over untreated or cytosine supplemented cultures.  Cytidine 
did not affect Phase I growth.   
Concomitant with the transition from Nine Mile Phase I to Phase II, several genes 
encoding nucleotide sugar synthesis within LPS pathways are deleted from the 
chromosome (Hoover et al., 2002).   In the present study, we likewise suspected that 
previously undetected deleted or point-mutated gene(s) might explain the cytidine 
deficiency in Phase II.  In bacteria, cytidine auxotrophy is often explained by dysfunction 
in CTP synthase.  Thus, we also examined the CTP synthase gene (pyrG) and enzyme 
function in Phase II organisms. 
 
Materials and Methods 
C. burnetii growth in BHK-21 cell culture   
All procedures that involved use of viable C. burnetii were performed under 
biosafety level 3 conditions as recommended in Biosafety in Microbiological and 
Biomedical Laboratories (USPHS, 1999).  Baby hamster kidney (BHK-21) cells (ATCC 
no. CCL-10, American Type Culture Collection, Manassas, VA) were cultured in 
complete growth medium [Dulbecco’s Modified Eagle Medium (D-MEM; without 
sodium pyruvate), containing 4.5 g/L glucose (Life Technologies, Rockville, MD) and 
5% fetal bovine serum (FBS) (Life Technologies)] in 25-cm2 tissue culture flasks 
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(Corning, Corning, NY).  During all cell culturing procedures, the flasks were incubated 
at 37oC in the presence of 12% CO2 (Chen et al., 1990; Zuerner & Thompson, 1983) until 
the cells reached 100% confluence within the flask (approximately 5 days).  On the day 
of infection, 1.1 x 106 BHK-21 cells were placed into each of two 25-cm2 flasks (paired 
experiments A and B) and allowed to attach to their surfaces for 12 hours.  The 
monolayers were infected for 12 hours in incomplete growth medium (i.e., without 5% 
FBS) containing either 1.2 x 106 C. burnetii Nine Mile Phase I (clone 7) or Phase II 
(clone 4) organisms (Organism particle counts were established by the use of a variation 
of a Gimenez staining technique described previously (Miller & Thompson, 2002).).  The 
inocula were organisms from 50% (W/V) yolk sac seed stock (Miller & Thompson, 
2002) diluted in phosphate-buffered saline (pH 7.2) to achieve a multiplicity of infection 
(MOI) of one organism per host cell.  After inoculation, the incomplete medium was 
replaced with complete growth medium.  Three days after infection, the cells were treated 
with 1ml of trypsin (1mg/ml), and diluted 1/20 with complete growth medium and then 
uniform samples of infected cells were placed into six 25-cm2 tissue culture flasks 
(Corning).  For each infection, duplicate tissue culture flasks were either left untreated, 
supplemented with 1 mM cytosine, or supplemented with 1 mM cytidine.  Throughout 
this report, the day that supplements were added to the complete growth medium is 
referred to as day 0.  Two tissue culture flasks containing uninfected BHK-21 cells were 
maintained as negative controls.   
Cell counting 
Samples were taken at 5-day intervals from each flask throughout the 25-day 
experiment.  Complete growth medium was exchanged every third day after sampling.  
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Infected cultures were split every 5 days, at a 1/20 dilution.  To prepare samples, 50 µl of 
trypsin-treated cells in medium from Phase I- and Phase II-infected cells was placed onto 
duplicate microscope slides and uniformly spread, by dragging a clean slide across the 
sample, to obtain a thin film.  The smears were air-dried, heat-fixed, and immersed in 
acetone for 15 minutes at room temperature.  The slides were stained with the Gimenez 
technique (Gimenez, 1964).  Prepared microscope slides were stored in the dark at room 
temperature until examined.  C. burnetii Phase I and Phase II organism counts were 
determined by scanning the slide for fields of diffuse, stained host cells on a Nikon 
Eclipse E800 microscope (Nikon USA, Melville, NY).  Stained cells were centered in a 
field under 1000 x magnification, and the red-stained organisms within the blue-green 
host cell cytoplasm were enumerated with the aid of a digital counter.  Cells were 
rejected from the count only when the BHK-21 cells were unstained or poorly stained.  
Dense concentrations of organisms that could not be accurately counted were recorded as 
“too numerous to count” (TNTC).  Eighty BHK-21 fibroblasts were counted per 
treatment condition (i.e., untreated, cytosine supplemented, or cytidine supplemented) at 
each time point to obtain a representative sampling of host cells.  Data from paired 
experiments (A and B) of both Phase I and Phase II organisms were compiled and 
analyzed by the number of C. burnetii organisms (Phase I or Phase II) per host cell per 
growth condition (untreated or cytosine or cytidine supplement) (Figure 6).  Three-
dimensional bar graphs were used to organize and depict the number of host cells 
infected, the total number of organisms, and the number of Phase I and Phase II 
organisms in each cell when cultured in the specified growth conditions over time (days 
0-25) [Figures 7-9].  Data were graphed using Sigma Plot 2001 (SPSS, Inc., Chicago, IL). 
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Statistical analyses 
Growth differences in C. burnetii by experiment (A or B) at each time period 
(days 0, 5, 10, 15, 20, 25) were assessed by analysis of variance (Kleinbaum et al., 1998).  
Since multiple comparisons by experiment and treatment type were conducted for each 
time period, p-values were adjusted using the Tukey-Kramer method to be more 
conservative in rejecting the null hypothesis of no significant differences in growth 
density (organisms per cell) of C. burnetii by the presence or absence of supplement 
(Dunnett, 1980).  Differences in mean values by group that resulted in p-values <0.05 
were considered statistically significant.  Multiple regression analysis was used to 
evaluate trends in growth density over time by experiment and supplement (Kleinbaum et 
al., 1998).  Time-squared terms were evaluated for improved model fit as were 
interaction terms between supplement type and time.  All statistical analyses were 
performed using SAS software (version 8.2; SAS Institute, Cary, NC). 
Mixing experiments utilizing Phase I and Phase II cell-free lysate 
 To examine if Phase II cell-free extract has an inhibitory effect on the CTP 
synthetase enzyme, recombinant C. burnetii purified enzyme was added to reaction 
mixtures containing varying concentrations of Phase I or Phase II cell-free extract to 
attempt to identify observed differences in recombinant enzyme activity.  Purified 
hexahistidine-tagged recombinant enzyme was frozen at –20oC at a concentration of 
1mg/ml in freezing buffer (Anderson, 1983).  Mixing experiments were performed by 
adding equal, 5-fold, 10-fold, and 20-fold concentrations (10, 50, 100, and 200 µg, 
respectively) of either Phase I or Phase II cell-free extract to a mixture containing 10 µg 
purified recombinant C. burnetii CTP synthetase, 1 mM ATP, 1 mM UTP, 0.2 mM GTP, 
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and pre-warmed (37oC) reaction buffer (0.06 M HEPES pH 8.0, 0.5 mM EDTA, 0.01 M 
glutamine, 0.01 M MgCl2, and protease inhibitor cocktail (Miller et al., Submitted)).  
Reaction mixture volumes were kept consistent at 1 ml to prevent dilution effects.  
Reactions were added to pre-warmed matched quartz cuvettes (Fisher Scientific, 
Suwannee, GA), and absorbance values were taken at 1 minute intervals for 10 minutes at 
OD291.  Reaction rates were calculated from the first five minutes of data following the 
conversion of UTP to CTP (∆ε 1338 M-1·cm-1 (Bearne et al., 2001)).  Background was 
corrected by using reaction mixtures without 1 mM UTP added.  Rates are reported as 
nanomoles CTP per minute per milligram of enzyme.   
 
Results and Discussion 
C. burnetii Nine Mile strain Phase I and Phase II organisms were introduced to 
BHK-21 fibroblasts at a low MOI (from 0.9 ± 0.1 to 1.0 ± 0.1 organisms per cell) to 
examine the initial stages of infection.  The growth increases measured are net increases 
in the population of organisms within an expanding BHK-21 population.  During the 25-
day period examined (Figure 6), Phase I organisms with or without nucleoside 
supplement displayed increases in growth until the numbers of organisms within the 
acidified phagosomes of the BHK-21 cells became too dense to count accurately 
(signified by an * on day 25, Figure 6a).  Phase I organism counts were statistically 
similar for both experiments throughout the 25 day experiment, with two exceptions (day 
5 experiment A, cytidine = 4.3 ± 0.3 organisms per cell, p = 0.02; day 15 experiment B, 
cytidine = 14.9 ± 1.2 organisms per cell, p = 0.0026).  For all other days, there were no 
 46
statistically significant differences in Phase I growth density by experiment, indicating 
that cytidine had either no effect or a minor effect on Phase I growth in BHK-21 cells. 
When the net growth rate of Phase II organisms in untreated and supplemented 
culture conditions was examined, it was found that Phase II cultures did not exhibit 
significantly different growth until day 10 (Figure 6b).  Thus, under conditions used here, 
we obtained no evidence for more rapid uptake of Phase II organisms.  From day 10 until 
day 25, the cytidine-supplemented cultures displayed significantly higher growth 
densities than the untreated and cytosine-supplemented cultures at every time point (p < 
0.001).  Phase II organisms infecting BHK-21 cultures supplemented with cytidine grew 
to between 9 to 11 organisms per cell on day 20, which was the peak of Phase II growth 
in the presence of cytidine.  This was a higher concentration of organisms per cell than 
observed in untreated or cytosine-supplemented conditions (from 3.3 ± 0.2 to 4.4 ± 0.3 
organisms per BHK-21 cell).  Phase II experiments A and B with cytidine supplement 
were not significantly different from one another over time.  We used multiple regression 
analysis to compare the growth curves of Phase II organisms in the untreated or 
supplemented culture conditions: over the 25-day time period, organisms grown with 
cytidine supplementation replicated to a significantly higher density than those grown 
with 1 mM cytosine or without supplementation (p<0.0001). 
To better understand the effect phase variation has on the growth of C. burnetii 
Phase I and Phase II organisms, we examined the net increase of Phase I or Phase II 
organisms in each host cell and compared the numbers of infected host cells by the 
bacterial load in each cell to search for growth trends in the experiments.  The growth 
data of Phase I organisms were statistically similar when results of the paired 
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experiments were compared.  The Phase II growth data were also statistically similar in 
the paired experiments.  Data from a Phase I and Phase II experiment were used as 
representative samples in Figures 7-9.  It was found that on day 0 both Phase I and Phase 
II organisms had infected similar numbers of randomly selected BHK-21 cells (50% of 
BHK-21 cells infected with Phase I vs. 52.5% infected with Phase II).  On day 5 of the 
Phase I infections, 60-70% of fibroblasts were infected (all variables), and by day 10, all 
fibroblasts contained at least some coxiellae (data not shown).  In Phase II infections, the 
corresponding infection rates were 65-78% (day 5) and 95% on day 10 (data not shown).  
Phase I organisms, regardless of supplement condition, increased in total bacterial 
numbers and bacterial load within the phagosomes of the host cells over time (Figures 7a, 
8a, 9a).  All Phase I conditions (untreated or supplemented) in both experiments resulted 
in high total bacterial numbers in observed BHK-21 cells (n = 80) by day 20 (Figure 7a: 
untreated = 2212 ± 72 bacteria; Figure 8a: 1 mM cytosine = 2077 ± 55 bacteria; Figure 
9a: 1 mM cytidine = 2278 ± 36 bacteria).  Each Phase I growth condition (untreated or 
supplemented) on day 20 also resulted in > 12% of the BHK-21 cell population 
displaying heavy infections (> 40 bacteria per cell, Figures 7a, 8a, 9a).  Thus the shift in 
Phase I cultures from lower to higher numbers of intracellular coxiellae between day 15 
and 20 was particularly noticeable, as was the striking appearance of a subpopulation of 
fibroblasts containing > 40 organisms (i.e., TNTC) (Figures 7a, 8a, and 9a--notice 
population bar patterns in 20-day columns).  Untreated and cytosine-supplemented Phase 
II cultures showed poor growth and low total numbers of bacteria in BHK-21 cells 
compared with those for Phase I cultures (Figure 7b: untreated day 25 = 227 ± 21 
bacteria; Figure 8b: 1 mM cytosine day 20 = 192 ± 6 bacteria).  Throughout the 
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experiment most untreated or cytosine-supplemented BHK-21 cells were infected with 2-
4 Phase II organisms/cell, and no BHK-21 cell was observed to contain > 15 Phase II 
organisms (Figures 7b and 8b).  When 1 mM cytidine was added to growth medium, the 
Phase II organisms displayed a 3-fold increase in total numbers of bacteria (Figure 9b: 
day 25 = 687 ± 29 Phase II organisms).  A comparison of data in Figures 7b and 9b 
clearly demonstrates the nature of the growth rate shift caused by cytidine in Phase II 
cultures.  The average infection in each BHK-21 cell shifted from 2-4 Phase II organisms 
per cell to 6-10 Phase II organisms per cell (Figure 9b).  Furthermore, the cultures treated 
with 1 mM cytidine had more BHK-21 cells infected with ≥ 15 Phase II organisms 
(Figure 9b).  This effect was not due to greater cell-to-cell spreading or to a higher rate of 
initial infection: it was clearly a reflection of the intracellular replication rate of Phase II 
organisms.  Of interest, this growth effect requires several days of culturing with cytidine 
before becoming evident.    
It was known from previous work that Nine Mile Phase II is a deletion mutant 
(Hoover et al., 2002; Thompson et al., 2003).  Assuming that cytidine within the 
supplemented media would contribute to an increase in host cell nucleoside pools, and 
thereby be available to the intracellular coxiellae, we reasoned that the results may 
indicate a genetic deficiency in the cytidine pathway of the Phase II strain.  A critical step 
in de novo synthesis of cytidine is the conversion, in nucleotide form, from UTP to CTP 
by CTP synthase.  Cloning and characterization of the CTP synthase gene (pyrG) 
revealed however that it is present without sequence defects in Phase II organisms (Miller 
et al., Submitted).  Enzyme function experiments conducted with dialyzed, crude extracts 
from freshly prepared, highly purified Phase I and II organisms grown in yolk sacs 
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revealed that both extracts possessed at least some CTP synthase activity (Miller et al., 
Submitted).  Since CTP synthase is a homotetrameric enzyme in active form and is 
allosterically regulated, a regulatory explanation also had to be considered.  Thus we used 
a recombinant C. burnetii CTP synthase expressed in and purified from Escherichia coli 
(Miller et al., Submitted) in attempts to rule out the presence of any small or large 
molecule inhibitors in Phase II cells.  This was accomplished by the addition of Phase I 
and II extracts to purified, hexahistidine-tagged enzyme; such experiments showed no 
inhibitory effects (Table 1).   
Thus, we have no concrete explanation for the stimulatory effect of cytidine in 
these culture experiments.  Because the addition of cytidine to Phase I-infected cells does 
not result in an effect similar to that seen in Phase II cultures, it seems doubtful that this 
is solely a host response that is resulting in a different signal to Phase II compared with 
Phase I organisms.  It may instead be a difference in response by the different phase 
organisms to a host signal or condition.   
In conclusion, we have described here a method of achieving differential growth 
that can distinguish between C. burnetii Phase I and II organisms.  This method is more 
specific than established PCR methods (Brennan & Samuel, 2003) in that it can 
differentiate between a large number of host cells infected with a very few bacteria or a 
few host cells infected with a large number of bacteria.  As methods of genetic 
manipulation of coxiellae develop, the application of this tool in genetic complementation 
experiments may make it possible to predict the success of gene recombinants in 
restoring virulence to Phase II organisms.  This system could be employed prior to testing 
such recombinants in more expensive and difficult animal virulence models.  At the very 
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least, this will prove to be an interesting way to characterize new isolates as well as some 
poorly characterized strains of lower virulence.  Presently, we do not completely 
understand why, under these conditions, Phase I organisms grow preferentially well, to 
the exclusion of Phase II.  However it is likely that the increased CO2 levels (12 %) and 
the very high glucose concentration (4.5 g/L) used in the culture medium causes rapid 
acidification of host cell cytoplasms, as has been described before in animal cell 
physiology studies (Arathoon & Telling, 1981; Sato, 1994).  This could certainly affect 
the ease of parasitophorous vacuole acidification, which may be beneficial to Phase I 
organism growth.  The organism is a moderate acidophile (Hackstadt & Williams, 
1981b).  The mechanism underlying the differential effect that these growth conditions 
have upon Phase I and Phase II cultures remains to be satisfactorily explained.  In this 
regard, it is pertinent to understand that the lysosomal pathway taken by the Phase I 
organism likely differs from that of Phase II.   As discussed, this is believed to be a 
consequence of their different cell entry mechanisms (Capo et al., 1999; Mege et al., 
1997).  The subsequent differences in intracellular trafficking may lead to a vacuole of 
differing pH for Phase I or Phase II organisms, with the Phase II vesicle having a lower 
pH than the Phase I vesicle.  This idea has indeed been proposed, and there is some 
evidence supporting it (Ghigo et al., 2002).  Thus in the present experiments, Phase II 
growth might be almost completely abrogated by overacidification, whereas in Phase I 
culturing the effect is stimulatory or of no consequence.     
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Table 1:  Mixing experiments using Phase I and Phase II cell-free extract.  Data are 
reported as nmol CTP/min per mg enzyme.  Each data set was performed in triplicate.  
Error is reported as SD.  Ten µg recombinant C. burnetii CTP synthetase in the absence 
of Phase I or Phase II protein displayed a reaction rate of 1607 ± 54 nmol CTP/min per 
mg enzyme.  The negative control exhibited a rate of 5.0 ± 31 nmol CTP/min per mg 
enzyme.   
  
 
10 µg extract
50 µg extract
100 µg extract
200 µg extract
1599 ± 49
1570 ± 49
1465 ± 119
1562 ± 112
1637 ± 27
1662 ± 19
1672 ± 30
1530 ± 35
Phase I Phase II
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Figure 6: Growth curves of C. burnetii variants in BHK-21 host cells.  C. burnetii 
Nine Mile strain Phase I (1a) and Phase II (1b) organisms were grown in BHK-21 cells in 
tissue culture medium left untreated (circles), in the presence of 1 mM cytosine 
(triangles), or 1 mM cytidine (squares).  Experiment A data are represented by closed 
symbols, while Experiment B data are represented by open symbols.  The x-axis 
represents days, and the y-axis signifies the number of C. burnetii organisms in the 
acidified phagosomes of BHK-21 cells.  Each point represents the mean number of 
bacteria cells per host cell in 80 randomly counted BHK-21 cells.  Error bars represent 
standard error.  * signifies that the number of C. burnetii organisms were too dense to 
count accurately.  
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Figure 7: C. burnetii Nine Mile strain untreated Phase I (a) and Phase II (b) 
distribution in BHK-21 cells.  Representative samples of the data are shown.  The x-axis 
signifies the number of C. burnetii organisms counted in each randomly selected host 
cell.  The y-axis represents the number of BHK-21 cells in each bar.  The z-axis 
represents the days on which organisms were stained and enumerated in host cells (20 
days for Phase I organisms and 25 days for Phase II organisms).  Graphs are shown as an 
alternating black and white pattern to make the data bars easier to distinguish. 
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Figure 8: C. burnetii Nine Mile strain Phase I (a) and Phase II (b) distribution in 
BHK-21 cells treated with 1 mM cytosine.  Representative samples of the data are 
shown.  The x-axis signifies the number of C. burnetii organisms counted in each 
randomly selected host cell.  The y-axis represents the number of BHK-21 cells in each 
bar.  The z-axis represents the days on which organisms were stained and enumerated in 
host cells (20 days for Phase I organisms and 25 days for Phase II organisms).  Graphs 
are shown as an alternating black and white pattern to make the data bars easier to 
distinguish. 
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Figure 9: C. burnetii Nine Mile strain Phase I (a) and Phase II (b) distribution in 
BHK-21 cells treated with 1 mM cytidine.  Representative samples of the data are 
shown.  The x-axis signifies the number of C. burnetii organisms counted in each 
randomly-selected host cell.  The y-axis represents the number of BHK-21 cells in each 
bar.  The z-axis represents the days on which organisms were stained and enumerated in 
host cells (20 days for Phase I organisms and 25 days for Phase II organisms).  Graphs 
are shown as an alternating black and white pattern to make the data bars easier to 
distinguish. 
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Abstract 
Knowledge about transport in Coxiella burnetii, an obligate phagolysosomal 
parasite, is incomplete.  We investigated the capability of isolated, intact, host-free 
Coxiella to transport ribonucleosides while incubated at a pH value typical of lysosomes.  
Because of the low activities and limitations of obtaining experimental quantities of 
isolated, purified Coxiella, incorporation of substrate into nucleic acid was used as a trap 
for determination of uptake abilities.  Virulent wild type (Phase I) organisms possessed 
uptake capability for all ribonucleosides.   Both Phase I and Phase II (avirulent) 
organisms incorporated the purine nucleosides guanosine, adenosine, and inosine, and 
showed a more limited uptake of thymidine and uridine.  Both phases were poorly active 
in cytidine uptake.  Neither phase of the organism was capable of transport and 
incorporation of NTPs, CMP, cytosine, or uracil.  Water space experiments confirmed 
that the uptake process concentrated the purine nucleosides within the cytoplasm of both 
wild type and Phase II Coxiella via a low pH-dependent mechanism.  Comparison of 
uptake rates in Escherichia coli versus Coxiella verified that the incorporation of 
ribonucleosides by Coxiella is a slow process.  It is concluded that Coxiella possesses 
some transport pathways consistent with utilization of pools of nucleosides found within 
its host cell lysosomal pathway.  
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Introduction 
Intracellular parasites are dependent upon their host cell for metabolic precursors 
and raw materials for replication.  Of importance is how parasites obtain nucleotides for 
nucleic acid and nucleotide sugar synthesis, cofactor metabolism, and energy supply.  
Species of Legionella show an increased growth rate in medium supplemented with 
guanine, adenine, cytosine, thymine, and uracil (Pine et al., 1986).   Rickettsia prowazekii 
uses an ADP-ATP transporter for adenosine nucleotide exchange with the host (Atkinson 
& Winkler, 1985; Austin & Winkler, 1988; Winkler, 1976).  R. prowazekii also possesses 
AMP, UMP, and GMP transport mechanisms to obtain nucleotides for metabolism and 
growth (Atkinson & Winkler, 1985; Winkler et al., 1999).  Early work by Hatch showed 
that Chlamydia psittasii utilized nucleoside triphosphates from the host cell to synthesize 
parasite RNA (Hatch, 1975); some of this synthesis is parasite stage-specific (Crenshaw 
et al., 1990).  C. psittacii also possesses a ATP/ADP exchange transporter similar in 
function to that seen in R. prowazekii (Hatch et al., 1982).   Chlamydia trachomatis must 
transport purine nucleotides and uracil from its host cell to compensate for a lack of 
ability to form deoxyribonucleoside triphosphates (dNTPs) de novo (McClarty & Tipples, 
1991; McClarty & Qin, 1993), and is believed to have separate nucleotide transport 
pathways for energy supply and RNA synthesis (Tjaden et al., 1999).  
Coxiella burnetii causes Q fever in humans, is a moderate acidophile, and 
replicates in end stage lysosomes within phagocytic cells (Hackstadt & Williams, 1981b; 
Heinzen et al., 1996b).  Aside from its known acidophilic physiology, little is known 
about how it interacts with the host while residing within this niche.  The lysosomal 
pathway does contain a large quantity of protein and nucleic acid precursors (Barrett, 
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1984; Pisoni & Thoene, 1989; Pisoni & Thoene, 1991).  Coxiella could take advantage of 
these in its growth process.  Despite its moderate genome size [2100 kbp; (Willems et al., 
1998)] Coxiella has never been successfully cultured outside of eukaryotic cells.  A 
limited knowledge of its metabolic capabilities has been gained chiefly through two 
techniques; (a) enzymatic studies with cell-free cytoplasmic extracts [for review see 
(Thompson, 1988)], and  (b) by use of a technique called acid activation in which intact, 
host-free Coxiella in axenic media are subjected to a pH typical of lysosomes, e.g., pH 
4.0-5.5 (Hackstadt & Williams, 1981b).  Coxiella cells are metabolically inactive at 
neutral pH.  
Fragmentary data concerning the uptake of nucleosides and nucleotides by 
Coxiella can be found in previous studies reporting on bacterial transcription and 
replication processes (Chen et al., 1990; Hackstadt & Williams, 1981c; Samuel et al., 
1988; Zuerner & Thompson, 1983).  Purified, host-free organisms of the Phase I variant 
of the Nine Mile strain incorporated thymidine, uridine, and adenosine into 
macromolecular material (Hackstadt & Williams, 1981c); this incorporation required an 
acidic pH and a concomitant energy source (such as glutamate).  A considerable portion 
of the guanosine taken up appeared to be catabolized (Hackstadt & Williams, 1981c).   
One study (Zuerner & Thompson, 1983) employing two populations of C. burnetii 
harvested from BHK-21 fibroblast cell cultures showed that these differed with respect to 
incorporation of uridine.  Organisms recovered from the tissue culture medium of 
persistently infected fibroblasts, termed ‘naturally released’ Coxiella burnetii, were 
deficient in uridine incorporation into RNA during acid activation.  Organisms obtained 
by the mechanical lysis of heavily infected host cells, however, were capable of 
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incorporating uridine into RNA under similar (low pH) conditions.   In a similar study on 
DNA synthesis in acid activated C. burnetii, the inability of naturally released organisms 
to incorporate thymidine during acid activation was also noted (Chen et al., 1990).  This 
lack of thymidine incorporation was suspected to be a nucleoside permeability problem in 
the extracellular stage of Coxiella, since the use of 32P-orthophosphate as a precursor 
demonstrated that these cells could synthesize DNA.  In the latter study, it was 
established that a relatively high external concentration of thymidine was necessary to 
observe DNA host cell-free synthesis in Coxiella and that sucrose was also necessary, 
presumably to ensure osmotic stability.    
Recent investigations upon the genetics of phase variation in Coxiella have 
focused on the need to study lipopolysaccharide pathway steps, particularly those 
concerned with nucleotide sugar synthesis and metabolism.  The present work surveyed 
nucleic acid precursor uptake in both Phase I (wild type) and Phase II (analogous to 
rough lipopolysaccharide phenotype) organisms released from their host embryo 
endodermal cell growth sites by mechanical lysis.  The metabolic and transport 
capabilities of Coxiella Phase I and Phase II organisms had not previously been 
compared.   
In this report, we show that Coxiella actively concentrates purine ribonucleosides 
within its cytoplasm.  No evidence was found for transport or diffusion of NTPs, CMP, 
cytosine, or uracil into Coxiella.  Although Phase II organisms were found to be 
qualitatively similar in many respects, they were generally slower in uptake for most 
nucleosides tested, and less active in their ability to concentrate inosine and adenosine.  
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Materials and Methods 
Biosafety   
All work described on Coxiella burnetii Nine Mile Phase I organisms was 
conducted under BSL3 conditions.   Since the organism is highly infectious, procedures 
that could accidentally discharge aerosols, such as tissue disruption, blending, and 
pipetting, were conducted in a biological safety cabinet (BSC).  Respirators were used 
during other procedures that were deemed potentially risky but unable to be carried out in 
a BSC. 
Bacterial Strains and Culturing   
C. burnetii Nine Mile Clone 7 (Phase I) and Clone 4 (Phase II) were plaque 
purified by Mort Peacock at Rocky Mountain Laboratory and provided by James Samuel 
and David Waag; seed stocks used were within two egg passages of these clones.  They 
were cultured in the yolk sacs of seven-day-old White Leghorn antibiotic-free 
embryonated eggs (SPAFAS, Inc.: Norwich, CT) at a growth temperature of 36oC.   
Harvests were performed when a fifty percent kill was observed, usually at day eight 
(Phase II) or day nine (Phase I).  Yolk sacs were stored at 4oC in groups of five.  After 
each batch harvest was completed, the purification of Coxiella was immediately started.   
Storage groups were screened for contaminating bacterial growth using sheep blood agar 
plates.   
  Escherichia coli ATCC 25922 strain was grown in Luria-Bertani (LB) broth until 
the organisms reached an OD600 of 0.5 (Beckman Model 25 Spectrophotometer; Beckman 
Coulter, Inc.: Fullerton, CA).  E. coli were used for incorporation experiments 
immediately or stored on ice for 21 hours before use. 
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Purification of Coxiella strains    
The methods used differed significantly from those yolk sac purification methods 
described previously (Paretsky et al., 1958; Williams et al., 1981).  All steps were 
performed at 4oC.  Yolk sacs were homogenized in batches of 120 g each, with 120 ml 
SPG buffer (0.7 M sucrose, 3.7 mM KH2PO4, 6 mM K2HPO4, 0.15 M KCl, 5 mM 
glutamic acid, pH 7.4) using 400 ml homogenization chambers and Omni Mixer 
Homogenizer Model 17105 (Omni International: Warrenton, VA).  Sacs were 
homogenized for 10 minutes, alternating every 30 seconds between 4400 rpm and 10,300 
rpm while the chamber was bathed in an ice slurry.  An additional 60 ml SPG buffer was 
added and homogenization continued for another 10 seconds at 4400 rpm.  The 
homogenates were centrifuged in 250 ml bottles (Nalgene Nunc International: Rochester, 
NY) at 1020xg in a Sorvall GSA rotor (Kendro Laboratory Products: Newtown, CT) for 
15 minutes.  Supernates were centrifuged at 9000xg for 90 min (GSA rotor).   Supernates 
were discarded, and the fat on the bottle walls removed by sterile cotton swabs.   Pellets 
were resuspended in 60 ml SPG buffer, combined, and the differential centrifugation 
steps repeated.  Pellets were suspended in 120 ml SPG buffer, 15 grams of acid-washed 
celite added, and the slurry shaken vigorously.   Following centrifugation at 418xg for 15 
minutes, the supernatants were recentrifuged (GSA rotor, 1280xg, 15 minutes) to remove 
celite.  The resulting Coxiella containing supernates were added to round-bottom 
centrifuge bottles and centrifuged at 9000xg for 90 minutes.  Each pellet was resuspended 
in 25 ml of SPG buffer and 1 ml of Trypsin (1 mg per ml; Life Technologies: Rockville, 
MD) then digested at room temperature for 30 minutes.  After the suspension was 
separated in a SS34 rotor (Kendro Laboratory Products) at 271xg for 15 minutes, the 
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resulting supernates were centrifuged again in a SS34 rotor at 30880xg for 30 minutes.  
Purified pelleted organisms were resuspended to a total volume of 70 ml of buffer A 
[22.3 mM K2HPO4, 135.7 mM KCl, 13.4 mM NaCl, 89 mM glycine, 10 mM 
MgCl2•6H2O, 1 mM glucose, 1 mM glutamate, and 250 mM sucrose, pH 7.0; (Zuerner & 
Thompson, 1983)].  To remove residual impurities, the organisms were banded through 
sterile stepped sucrose gradients prepared by layering, in order, 3 ml of 2M sucrose, 2 ml 
of 1.2M sucrose, and 1 ml each of 1.0M, 0.8M, and 0.6M sucrose assembled in 12 ml 
polycarbonate tubes  (Kendro Laboratory Products).   After layering 2.5 ml of Coxiella in 
buffer A onto these gradients, they were centrifuged in an HS-4 rotor (Kendro Laboratory 
Products) at 9430xg for 2 hours.  The purified Coxiella banded at the interface between 
the 1.2M and 2M sucrose layers; this zone was removed, combined, diluted with buffer 
A, and collected by centrifugation (Sorvall SS34 rotor at 30880xg for 1 hour). The 
resulting pellet was resuspended in 10 ml of buffer A for every 240 g of yolk sac starting 
material and immediately used in acid activation studies.  One half milliliter of this 
preparation was routinely retained for microbial enumeration (below).  
Enumeration of bacteria   
Viable counts for E. coli ATCC 25922 strain were determined by the CFU 
method. 
Smooth suspensions of Coxiella burnetii, in 0.5 ml buffer A, were transferred  
to a 1.7 ml microcentrifuge tube and centrifuged at 10000xg for 10 minutes (Beckman  
Microfuge Model 12).  The supernate was discarded and the pellet was resuspended in  
0.5 ml 0.2M NaCl.  Then 100 µl of this Coxiella suspension was added to 1.79 ml of  
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5% formalin and 200 µl of 0.2M NaCl and thoroughly mixed.  Equal volumes of the 
Coxiella mixture and a twice-filtered solution of freshly prepared carbolfuchsin  
stain (Gimenez, 1964) were mixed.  The Shigella flexneri were grown and inactivated as 
described (Silverman et al., 1979), and the standard was prepared by adding 0.1 ml of a 
well-suspended Shigella preparation (2.84 x109 organisms/ml) stored in 5% formalin to 
4.4 ml H2O, 0.1 ml of 0.2 M NaCl, and 0.2 ml of twice filtered Gram's crystal violet 
stain, followed by thorough mixing.  After combining 1 ml of the stained Coxiella and 1 
ml of the stained Shigella, the components were mixed, 10 µl of suspension applied to a 
microscope slide, and air-dried.  The number of Coxiella (red) and Shigella (purple) 
organisms in 30 fields (2 mm square area on an ocular grid) were determined.  The 
organisms were easily discernable by their size difference.  The ratio of Coxiella/Shigella 
organisms in the sample was used to calculate the direct Coxiella count expressed as 
organisms per ml. 
Incorporation Experiments   
Aliquots of Coxiella Phase I in Buffer A (50 µL), Phase II in Buffer A (200 µL), 
or E. coli ATCC 25922 strain in LB broth (1.5 ml) were transferred to reaction tubes and 
the tubes centrifuged for 10 minutes at 10000xg to pellet the bacteria.  After careful and 
complete removal of the supernate fluids, the pellets were resuspended in the appropriate 
medium [buffered salts (Hackstadt & Williams, 1981b; Zuerner & Thompson, 1983) 
fortified with 5.5 mM glucose, 0.3 mM thymidine*, 4 µM proline, 8.8 µM isoleucine, 
25.4 µM arginine, 6.8 µM serine, 46.4 µM glutamine, 4.0 µM valine, 2.4 µM tyrosine, 
3.4 µM aspartate, 2.2 µM histidine, 2.3 µM methionine, 8.8 µM leucine*, 3.9 µM 
threonine, 3.5 µM glycine, 9.6 µM cystine, 6.2 µM lysine, 2.0 µM phenylalanine, 8.7 µM 
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asparagine, 0.5 µM tryptophan, 3.96 µM alanine, and 2.4 mM glutamate] buffered to 
either pH 4.5 or pH 7.0.  Forty µCi quantities of 3H-labeled amino acid, nucleoside, 
nucleotide, or nucleobase were added, and then the organisms (in pellet form) were 
suspended in the medium, to a final volume of 0.8ml.  Cold (non-radioactive) leucine or 
thymidine (signified by *) was excluded from the axenic medium when radiolabeled 
leucine or thymidine was added to the solution.  The tracers used in the incorporation 
experiments were: leucine [4,5-3H, 133 Ci/mmol], inosine [2,8-3H, 44.4 Ci/mmol], 
adenosine [2,8-3H, 40.0 Ci/mmol], ATP [2,8-3H, 22.5 Ci/mmol], cytosine [5-3H, 22.8 
Ci/mmol], cytidine [5-3H, 17.7 Ci/mmol], CMP [5-3H, 32.3 Ci/mmol], CTP [5-3H, 23.0 
Ci/mmol], uracil [5,6-3H, 34.0 Ci/mmol], uridine [5-3H, 9.3 Ci/mmol], guanosine [8-3H, 
12.5 Ci/mmol], and thymidine [methyl-3H, 2.0 Ci/mmol] (Amersham Pharmacia Biotech: 
Piscataway, NJ, and Moravek Biochemicals: Brea, CA).  The reaction mixtures were 
incubated at 37oC in a gyrotory water bath shaker.  Samples (100 ul each) were taken at 
0, 1, 2, 4, 8, and 16 or 18 hours and pipetted onto Whatman 3 MM glass fiber disks 
(Whatman Inc.: Clifton, NJ).  The disks with the bound precipitated material were then 
prepared for scintillation counting by a slight modification of the method of Mans and 
Novelli (Mans & Novelli, 1960) as described (Chen et al., 1990; Zuerner & Thompson, 
1983).  The filters were counted by liquid scintillation while immersed in 10 ml of TT76 
(7 parts Triton X-100 [Sigma-Aldrich: St. Louis, MO], 6 parts Econofluor [New England 
Nuclear: Boston, MA]).  Tritium counts were determined in a Wallac Model 1410 
scintillation counter (Wallac: Turku, Finland).  Results were plotted in Sigmaplot ver. 5 
(SPSS Inc.: Chicago, IL), as picomoles or femtomoles substrate incorporated per 109 
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bacteria versus time (hr) and the slopes (from time zero to 4 hr) obtained using Microsoft 
Excel 1997 (Microsoft: Redmond, WA).  
Water Space Assay   
Purified Phase I and Phase II organisms were suspended in 10 ml of buffer A.  
Aliquots of 1 ml (1-4x1010 Coxiella) were pipetted into eppendorf tubes and pelleted for 
10 minutes at 10,000xg.  The pellets were resuspended in a solution of either neutral (pH 
7.0) or acidic (pH 4.5) medium (as described for incorporation studies, above) containing 
8 µCi/ml 3H-labeled H2O (1 mCi/mmol) and 1 µCi/ml of 14C-labeled compound.  The 
radiochemicals employed, and their specific radioactivities, were: 14C-sucrose (495 
mCi/mmol), 14C-inulin carboxylic acid (5.2 mCi/mmol), 14C-methoxy-inulin (12.1 
mCi/mmol), 14C-adenosine (50 mCi/mmol), 14C-guanosine (53 mCi/mmol), 14C-inosine 
(48 mCi/mmol), 14C-thymidine (53 mCi/mmol), 14C-cytidine (55 mCi/mmol), and 14C-
uridine (54 mCi/mmol).  To prevent incorporation into RNA, rifampicin at a final 
concentration of 40 µM was included in the incubation mixtures (Chen et al., 1990; 
Winkler et al., 1999).  Neutral pH (7.0) controls were run for each substrate.  To examine 
guanosine transport, Coxiella Phase I organisms were resuspended in axenic medium 
either with or without 40 µM rifampicin at both pH 4.5 and pH 7.0.  To further examine 
the energy dependence and competition for the transporter, the proton ionophore carbonyl 
cyanide m-chlorophenyl hydrazone (CCCP) (final concentration 0.05 mM; Sigma-
Aldrich) or cold guanosine (final concentration 20 µM; Sigma-Aldrich) were added to the 
reaction mixtures in the presence of 40 µM rifampicin at either time 0 or at 40 minutes 
into the incubation.  Finally, 2 mM KOH (10 µl per ml sample) was added to the axenic 
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medium at pH 4.5 at 40 minutes to neutralize the medium and thus examine the pH 
dependence of the guanosine transporter during concentrative work.   
Mixtures were divided into three equal parts (300 ul reaction volumes) and 
incubated for 1 hour at 37oC in a shaking incubator   Upon completion, equal aliquots 
were layered over perchloric acid/dibutylphthalate /silicon oil step gradients; these were 
constructed, centrifuged, frozen, fractionated, and sampled as described (Winkler, 1986; 
Winkler et al., 1999).  Three separate determinations were made from each triplicate 
reaction.  Fractions from the gradients were placed in 20 ml scintillation vials as 
described with 10 ml of TT76 (described above).  The beta particle emissions from 
supernatant and pellet fractions were determined in a Wallac Model 1410 scintillation 
counter using MeV versus pulse height settings, determined empirically, that captured 
most of the tritium and carbon 14 energy in separate windows.  Count (cpm) data were 
treated for energy overlap and counting efficiency according to a formula based upon 
tritium and carbon-14 standards made within our experimental conditions (Total 3H DPM 
= [(X-gn)-{[(C-gn)/(D-gn)]•(Y-gn)}]•[(100/Ct eff 3H)].  Total 14C DPM = [({(C-gn)/(D-
gn)}•(Y-gn))+(Y-gn)]•[(100)/(Ct eff 14C)].  Where: gn = background DPM, X = 
Experimental sample 1, Y = Experimental sample 2, C = Control sample 1, D = Control 
sample 2.) 
The corrected count data were converted to microliter volumes as described by 
Winkler et al. (Winkler et al., 1999).  A significant increase in the 14C-substrate/tritiated 
water ratio in the pellet compared to the value found in the supernatant suggests 
concentration of that substrate (Winkler, 1986).  Carbon-14 substrate values must first be 
corrected for extracellular water space (14C-inulin) and for extracytoplasmic water space 
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(i.e. the extracellular space plus the periplasmic space as determined by sucrose). The bar 
graphs depict the corrected ratio of pellet divided by supernatant with a value of 1 
suggesting complete diffusion into the cell, such that the interior and exterior 
concentrations of the substrate are equal.  A value of 2 indicates a two-fold concentration 
within the cell cytoplasm (Winkler, 1986).  The 3H and 14C values for all of the 
compounds (3H2O and 14C-labeled inulin, sucrose, adenosine, inosine, guanosine, 
cytidine, thymidine, and uridine) were determined for Phase I and Phase II organisms, as 
depicted in the bar graphs (Figures 10a and b).   The values were graphed in Sigmaplot 
5.0.     
 
Results   
Growth of C. burnetii variants in embryonated eggs   
C. burnetii Nine Mile Phase I (virulent) and Phase II (avirulent) organisms were 
cultured in embryonated eggs for nine and eight days, respectively.  The yolk sacs were 
removed and the organisms were purified as described (Materials and Methods).  The 
organisms were enumerated compared to a Shigella flexneri standard (2.84 x 109 
organisms/ml) and expressed as number of Coxiella per gram yolk sac.  A comparison of 
four purification batches for each of the variants showed that Phase I organisms were 
recovered at a level almost twice that of Phase II organisms (1.44 x 109 ± 1.72 x 108 
Phase I organisms per gram yolk sac compared to 8.52 x 108 ± 1.54 x 108 Phase II 
organisms per gram yolk sac).  This lower recovery of the Phase II organisms in eggs, 
when compared to the growth and recovery of Phase I organisms, is consistent with 
another report (Waag et al., 1991). 
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Leucine Incorporation in Coxiella variants   
In studying Coxiella growth and transport, certain limitations become apparent.  
There is (i) difficulty in purifying sufficient quantities of active organisms in a timely 
manner.  Coxiella activities (ii) must be distinguished from those contributed by 
contaminating host components.  Finally, (iii) variations in measured activities between 
batches of purified organisms make interpretation of results difficult.   To meet the 
constraints of (i), organisms were grown in yolk sacs and rapidly harvested (see above), 
and purified.   To distinguish activities from those of the host (ii), controls were done 
under non activating conditions carried out at pH 7.0.  This control detects most 
neutralophilic activities due to host enzymes, and blood agar plating together with the pH 
7.0 control will help rule out non-Coxiella bacterial contamination.   Dealing with (iii) 
batch variations, especially when doing isotope tracer experiments, is especially 
problematic.  Metabolite pool sizes and enzymatic activities are not uniform from batch 
to batch.  However, the rate of incorporation of radioactive leucine into protein during 
acid activation has proven to be a general indicator of overall metabolic capability in 
Coxiella  [see also(Chen et al., 1990)].  Thus, a low leucine activity will usually parallel a 
lower capacity for DNA synthesis as well.  Some populations of Coxiella incorporate 
leucine normally but completely lack an uptake system for another substrate, such as 
thymidine.   To thus enable better interpretation of results, it was advantageous to include 
leucine incorporation controls in every acid activation experiment with Coxiella (see 
Table 2; otherwise not shown).  Leucine controls also ensured that the observed lack of 
uptake of nucleotides and bases was not due to poorly active preparations of cells (see 
also Table 2).   
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A total of eight batches of Coxiellae, four of Phase I and four of Phase II, were 
used in this study.  All of these were checked for leucine incorporation rates, and all were 
active.  A comparison of phase I vs phase II data was also done.  Although a couple of 
batches showed significant variation, differences between phases were not significant at 
any time point (not shown).   Incorporation of leucine into either phase was linear 
through 4 hr at least, and rates varied between 40 and 400 femtomoles•109  
organisms-1hr-1 with an average of about 120. 
Comparative Uptake Activities of Coxiella and Escherichia coli   
An additional challenge in studying Coxiella is its low metabolic activity.  In a 
comparative study with E. coli, incorporation data was obtained using the same pH 7.0 
medium employed for the neutral pH control in Coxiella experiments.  Aliquots were 
taken between 0 to 90 minutes.  The slope of the best-fit line was used to determine the 
rate.  Since the time required to obtain purified Coxiella from harvested yolk sacs was 21 
hours, we held the freshly grown E. coli cells in LB broth at 4oC for the same length of 
time prior to testing. The incorporation of label was complete by 45 min in E. coli, 
suggesting that the available nutrients had been depleted.  Ratios of uptake rates, as 
determined by dividing the E. coli rate (mole fraction/109 bacteria/hr, observed at pH 7.0) 
by the C. burnetii rate (mole fraction/109 bacteria/hr observed at pH 4.5), were 
determined for four substrates and were as follows; leucine 59; adenosine 229; inosine 
47; cytidine 2088. C. burnetii is substantially smaller than E. coli, and calculations reveal 
that an E. coli cell possesses approximately five times more surface area.  But even when 
such a surface area correction is applied, differences in nucleoside uptake activities 
between the two are significant.  Thus the low metabolic activities of Coxiella, and the 
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requisite difficulty in preparing larger batches of active organisms, precluded the 
practicality of performing transport experiments utilizing classical millipore filtration 
assays.  We therefore employed the use of incorporation into acid-insoluble material to 
estimate the ability of organisms to transport and utilize several nucleotides, nucleobases, 
and nucleosides.   
Incorporation of Nucleosides   
To study the transport and incorporation of nucleosides, nucleotides, and 
nucleobases in Coxiella variants, C. burnetii Phase I and Phase II organisms were 
resuspended in axenic medium supplemented with 3H-labeled substrates (as described in 
Materials and Methods).  The data are expressed as incorporation rates, as femtomoles 
per 109 organisms per hour (Table 2).    Because leucine incorporation rates generally 
predict the metabolic capability of a Coxiella preparation, we have included those rates 
for each nucleoside experiment.  None of the nucleotides or nucleobases supplemented to 
the axenic medium were incorporated in an 8 hour time period.  It was necessary to 
establish that all batches used in experiments were metabolically fit, even though they 
may not transport a given substrate (Chen et al., 1990; Zuerner & Thompson, 1983).  
This assurance was obtained by testing for leucine incorporation into protein (Chen et al., 
1990; Redd & Thompson, 1995; Zuerner & Thompson, 1983).  All batches used to study 
nucleotide and nucleobase uptakes were checked, and all possessed leucine incorporation 
activity.  In experiments utilizing radiolabeled ATP, several variations were used to lower 
the adenylate charge to encourage ADP/ATP exchange at either pH 4.5 or 7.0 [see also 
(Hackstadt & Williams, 1981a)] including substrate starvation, ATP synthase inhibition, 
and various preincubation protocols.  In no case did we measure any incorporation of 
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ATP (data not shown).  In almost all experiments, purine nucleosides were incorporated 
to a greater extent than pyrimidine nucleosides.  Thymidine was the exception, showing 
incorporation rates roughly equivalent to the purine nucleosides.  In all cases, uridine and 
cytidine produced low incorporation rates, suggesting that cytidine and uridine are not 
transported as efficiently as purine nucleosides and thymidine, or that their internal pool 
sizes and de novo syntheses are by comparison greater.   
When inosine incorporation by Phase I and Phase II variants was compared, it 
was found that inosine was incorporated at a faster rate in Phase I variants than in Phase 
II variants (Table 2 and Figures 10a & b). In both phases, this incorporation could be 
eliminated by the addition of 40 µM rifampicin.  Furthermore, inosine was consistently 
incorporated at a greater rate than adenosine.  This is interesting because in the lysosomal 
pathway, adenosine is quickly converted to inosine (Pisoni & Thoene, 1989; Pisoni & 
Thoene, 1991), and the substrates differ in structure only by an amino group on the ring.  
To examine the specificity of the inosine transporter, cold adenosine at concentrations 
one, five, and ten times greater than the concentration of radiolabeled inosine (0.375 µM) 
were included in the incubations to see if adenosine could compete with the inosine 
incorporation rate (Figure 10a).  It was found in a single experiment that at any 
concentration of adenosine, inosine incorporation was not adversely effected.  To the 
contrary, the addition of adenosine appears to have had a slight positive effect upon 
inosine incorporation, particularly at the 10 fold concentration (Figure 10a).    
 Guanosine incorporation in Coxiella Phase variants was compared (Table 2, 
Figure 11).  It was found in two separate experiments that purified Phase II organisms 
displayed incorporation of radiolabeled guanosine at pH 4.5, but not at pH 7.0 (Table 2, 
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exp 3 and 4;  Figure 11b).  When two batches of purified Phase I organisms were 
compared, it was found that the guanosine incorporation rates for pH 4.5 and pH 7.0 were 
similar over the sixteen-hour time course with both experiments (Table 2, exp 1 and 2; 
Figure 11a).  Metabolic activity had never previously been observed in Coxiella at pH 
7.0, the organism thought to be in an almost static state at neutral pH.     
Water Space Studies   
Incorporation assays can be used to indirectly study transport of substrates by 
treating the accumulation of substrate in an acid insoluble pool as a ‘sink’ after uptake 
(Winkler et al., 1999).  However, incorporation studies cannot distinguish between active 
transport processes that concentrate substrate, and passive mechanisms that do not.  
Furthermore, as we have shown above, some of the pyrimidine nucleosides were weakly 
incorporated by Coxiella.   Water space experiments were therefore performed to verify if 
any of the incorporated nucleosides studied here were concentrated inside the cytoplasm 
of Coxiella.  Interpretation of data in water space experiments absolutely depends upon 
nonconversion of labeled substrate.  These experiments were therefore run in the 
presence of rifampicin to prevent incorporation into RNA. 
 These water space assays confirmed many of the incorporation results by showing 
that all nucleoside substrates that were incorporated in the acid precipitation study had 
diffused into, or were actively concentrated within, Phase I and Phase II cells.  At pH 4.5, 
both Phase I and Phase II organisms had significant concentration of inosine (4.2 and 2.3 
cytoplasmic volumes, respectively; (Figure 12), but did not concentrate the nucleosides at 
pH 7.0.  Likewise, both phases concentrated guanosine (5.5 cytoplasmic volumes for 
Phase I, 5.2 for Phase II) at acidic pH.   Guanosine concentration was not observed at pH 
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7.0 for Phase I cells.  This is not surprising considering that incorporation assays did not 
show significant incorporation of guanosine at neutral pH until 2 hours (Figure 11a) but 
the water space incorporation assays were carried out for only one hour.  Adenosine was 
seen to be concentrated at pH 4.5 in Phase I cells (cytoplasmic volume 1.8), whereas the 
concentration effect observed in Phase II cells was marginal (1.1 at pH 4.5 and 1.4 at pH 
7.0; Figure 12).  Neither phase concentrated cytidine, and in fact the values for this 
nucleoside, at both pHs and in both phases of organisms, was less than 1.  Low values 
were also found for thymidine and uridine concentration in Phase I cells.  In no 
experiment were any of the pyrimidine ribonucleosides seen to be concentrated in either 
Phase I or II organisms.  We did not attempt these experiments with the nucleoside 
triphosphates, or with bases.   
Cytoplasmic volume was determined for both Phase I and Phase II variants from 
the water space experiments.  Coxiella Phase I variants had a larger cytoplasmic volume 
(18.35 ± 6.29 µl/1012 organisms, 2 experiments) than Phase II variants (9.78 ± 0.69 
µl/1012 organisms, 3 experiments).  By using the dimensions of 0.25 microns by 1.0 
microns for the average organism as measured by light microscopy, and employing the 
formula for the volume of a perfect cylinder, we calculate a displacement volume of 49 
microliters for 1012 Coxiella organisms.  The large difference between the measured and 
calculated volumes suggests that much of the “space” perceived in microscopic 
measurements of stained Coxiella burnetii does not equate to water-based cytoplasm.  
This calculation ignores the SCV (small cell variant) stage, which is about 0.6 microns in 
length and probably impermeant to sucrose and water (McCaul, 1991).  
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 To gain a greater understanding of the purine transport systems in Coxiella, the 
guanosine transporter was examined more closely using water space techniques to 
analyze inhibitor effects and efflux of unmodified nucleosides (Figure 13).  Guanosine 
concentration in Coxiella Phase I organisms was examined either in the absence (see bars 
1 and 2) or the presence (bars 3 and 4) of 40 µM rifampicin at both pH 4.5 and 7.0 to 
determine if guanosine uptake would increase in the absence of rifampicin at acidic pH.  
Surprisingly, it was found that there was no significant difference between the samples 
incubated in the presence or absence of rifampicin at acidic pH, suggesting that very little 
of the uptake observed after one hour (without rifampicin) was due to RNA synthesis.  
Coxiella Phase I organisms were also incubated with labeled guanosine and rifampicin in 
the presence of either CCCP (bar 5) or cold guanosine (bar 6) for one hour.  Because the 
addition of rifampicin (at the beginning of the experiment) did not significantly affect the 
quantity of the radiolabeled guanosine transported into the cell after 1 hour, it must be 
concluded that most of the internalized substrate observed after 1 hour had not yet been 
incorporated into RNA.  However, its uptake over this period was completely abolished 
by the protonophore CCCP (bar 5), suggesting that the maintenance of a proton motive 
force or more precisely, the ∆pH, was essential for uptake.  Further, the addition of 
unlabeled guanosine decreased the amount of labeled guanosine within the incubated 
Coxiella organisms (bar 6), indicating a specific binding site for guanosine exists.  
 Rifampicin has been used in all water space experiments to block nucleoside 
incorporation into RNA.  This will not block nucleoside incorporation into DNA, or 
nucleotide sugars.  Water space studies require an unaltered substrate to analyze 
concentration; otherwise it is another measure of incorporation into macromolecules.  To 
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examine substrate efflux from Coxiella in the presence of inhibitors and competitors, 
Coxiella Phase I organisms were resuspended in axenic medium at pH 4.5 supplemented 
with 3H2O, 14C-guanosine and 40 µM rifampicin (as described in Materials and 
Methods).  After 40 minutes of incubation at 37oC to preload the cells with radioactive 
guanosine, either CCCP (final concentration 0.05 mM, tube 7), unlabeled guanosine 
(final concentration 20 µM, tube 8), or 2 mM KOH (tube 9) was added to the reaction 
mixture.  The samples were then incubated at 37oC for an additional 20 minutes.  After 
the 40 minute period of acid activation, 25 to 50% of the labeled internalized substrate 
was diffusible upon addition of excess non-labeled compound, or by the addition of 
CCCP or KOH (see bars 7, 8, and 9 in Figure 13).  These results suggest that most of the 
internalized labeled substrates had been metabolized into non-diffusible compounds, 
perhaps to nucleotides through kinase activity, and into nucleotide sugars, or into DNA, 
but not into RNA.  A portion of the concentrated compound (between 1.7 and 3.9 
cytoplasmic volumes-Figure 13) remains an unaltered part of the nucleoside pool within 
the cytoplasm and can be diffused from the cell when treated with inhibitors or given a 
neutral pH environment.  The existence of this unaltered and diffusable portion of the 
nucleoside pool, once incorporated substrates have been taken into account, suggests the 
Coxiella Phase I organisms tested here were capable of the active transport of guanosine.   
 
Discussion  
The present study was undertaken to obtain a more comprehensive understanding 
of Coxiella’s capabilities in transport of nucleic acid precursors when studied under 
conditions that mimic phagolysosomes.  The data confirm that Coxiella differs 
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substantially from Chlamydia and Rickettsia in these activities (Hatch et al., 1982; Tjaden 
et al., 1999; Winkler et al., 1999).   This study has revealed no evidence for the transport 
of ATP, GTP, CTP, UTP, CMP, cytosine, or uracil by C. burnetii.  We have shown that 
at least one purine ribonucleoside (guanosine) is concentrated, a characteristic that 
suggests a carrier-mediated, active transport mechanism.  Pyrimidine ribonucleosides 
however were not concentrated under the conditions used, even though these were also 
incorporated into RNA over long time periods (Figure 14).   
In each experimental set, a pH 7.0 control incubation was used to rule out 
contamination with other bacteria, and to help eliminate the possibility that observed 
results were due to host activities that may have co-purified with whole organisms.   In 
all substrates tested except one, this control gave the expected results, i.e., no activity.  In 
the case of guanosine incorporation, no pH dependence was found in Phase I organisms. 
Since there was no evidence of contaminating microbes, and because the activity is 
rifampicin-sensitive and therefore of microbial origin, we conclude that the Phase I 
organisms do have some capability for long-term guanosine uptake at a neutral pH.  This 
observation was not however verified in water space assays.  This may have been due to 
the relatively shorter incubation times required for the water space experiments.  It is 
possible that the observation may indicate an actual guanosine uptake event that occurs 
during infection of cells prior to acidification of the Coxiella endosome.  Further 
experimentation will be required to elucidate the mechanism of neutral pH uptake of 
guanosine. 
Knowledge of Coxiella’s nucleotide biosynthesis pathways (including nucleotide 
salvage) is incomplete, making it difficult to assess its need for precursors supplied in the 
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phagolysosome.  It is known that some enzymatic activity, specifically aspartate 
transcarbamoylase activity and the subsequent reactions through orotate synthesis in the 
pyrimidine biosynthetic pathway, are present (Mallavia & Paretsky, 1963); the latter 
observation was confirmed and the pyrB gene was cloned and characterized (Hoover & 
Williams, 1990).  Because the organism can incorporate various nucleoside precursors 
into nucleic acid (Chen et al., 1990; Zuerner & Thompson, 1983), it can be inferred that 
the required nucleoside diphosphate kinases are present to convert nucleosides to 
nucleotides.  Christian and Paretsky (Christian & Paretsky, 1977) demonstrated some of 
these activities within cell-free extracts obtained from purified Coxiella.  Genome 
analysis, now in progress for C. burnetii, should provide more insight as to which 
nucleoside biosynthesis and salvage pathways are present. 
It is known that C. burnetii Nine Mile Phase I and Phase II organisms differ 
substantially in their lipopolysaccharide (LPS) structure.  Phase I organisms display non-
truncated LPS that possess three rare sugars: L-virenose (6-deoxy-3-C-methyl-gulose), 
dihydrohydroxystreptose [(3-C-hydroxymethyl)-lyxose], and galactosaminuronyl-α-(1-
6)-glucosamine.  Nine Mile Phase II LPS structures contain none of these sugars and are 
severely truncated (Amano et al., 1987; Schramek & Mayer, 1982; Schramek et al., 
1985).  Phase I and Phase II organisms differ in their susceptibility to phagocytosis 
(Kazar et al., 1975; Wisseman et al., 1967) and in their surface characteristics (Krauss et 
al., 1977; Vishwanath & Hackstadt, 1988), and therefore can be expected to differ in 
interactions with various substrates and structures [see discussion by(Thompson, 1988)].  
It is well known that rough mutants of Salmonella typhimurium and other species are 
affected in functions including transport, phage attachment, outer membrane protein 
 83
assembly, and intercellular interactions (Parker et al., 1992; Walsh et al., 2000).  These 
differences in outer membrane structure may cause the differences in nucleoside 
incorporation and concentration we observe here between the variants.  It may be that 
surface porins or structures of Phase II organisms are perturbed enough to cause a 
decrease in the ability to transport or diffuse nucleoside substrates across the outer 
membrane.  Another possibility is that the truncation of the LPS in Phase II organisms 
cause charged moieties on the outer membrane surface to become exposed, negatively 
affecting transport across the outer membrane.  Whatever the cause of the decreased 
transport and concentration of nucleosides, especially purines, across the Phase II 
membrane, the differences are not great enough to suggest that transport mechanisms 
(such as permease proteins) are genetically absent.  The data available does show a lack 
of pyrimidine ribonucleoside active transport in both Coxiella variants. 
In these studies, trypsin was used to help eliminate cellular host proteins from the 
Coxiella preparations during purification.  It is unlikely that trypsin has significant 
negative effects on phase I functions (Amano et al., 1984; Banerjee-Bhatnagar et al., 
1996; Paretsky et al., 1958).  We cannot rule out that the use of trypsin in purification 
may have had some small effect on substate entry in Phase II cells.   
It is concluded that both Phase I and Phase II organisms possess a modest ability 
to transport purine ribonucleosides when incubated in acidic medium.  It is not known to 
what extent Coxiella may modify the environment of its host phagolysosome.  If that 
compartment is unmodified, Coxiella may have adapted to this environment by utilizing 
the readily available concentration gradients of precursors within the host 
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phagolysosome.  It may then passively import some nucleosides while utilizing (directly 
or indirectly) the pH gradient to transport others. 
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Table 2: Comparison of incorporation rates of Coxiella Phase I and Phase II 
variants.  Phase I and Phase II organisms were resuspended in axenic medium (pH 4.5 
unless indicated otherwise) with 3H-labeled substrate and incubated for 16 hours at 37oC.  
Results from four separate experiments are shown.  Rates are expressed as femtomoles 
substrate per 109 Coxiella per hour, as determined by the slope of the best-fit line for the 
early time points (0-4 hours).  ND = Not Done.   All batches of either phase I or phase II 
were metabolically active as determined by the leucine incorporation index. 
Inosine
Adenosine
Guanosine 4.5
Thymidine
Uridine
Cytidine
Leucine
Nucleosides
Phase I Phase II
Amino Acids
Nucleotides
ATP
CTP
CMP
Nucleobases
Uracil
Cytosine
Guanosine 7.0
UTP
GTP
Exp 1
698
145
79
75
568
101
39
70
ND
-3
ND
-0.1
0.8
-1
-2
260
Exp 4
900
ND
1388
536
32
352
-1
-5
88
0.8
-1
1
ND
ND
Exp 3
315
45
112
53
215
19
12
42
-2
ND
0.4
ND
-3
ND
ND
Exp 2
2462
ND
342
305
ND
ND
102
334
-1
ND
-1
ND
ND
-3
-1
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Figure 10: Incorporation of inosine by Coxiella variants and competition with 
adenosine.  Purified Coxiella Phase I (a) and Phase II (b) organisms were resuspended in 
acidic medium supplemented with 40 µCi 3H-inosine and incubated at 37oC for 8 hours.  
At times 0, 1, 2, 4, and 8 hours, samples were removed and processed.  Results are 
expressed as femtomoles inosine per 109 Coxiella.  Rifampicin, when used, was added to 
a final concentration of 40 µM.  Cold adenosine was added in the competition 
experiments to a final concentration of 1, 5, or 10 times the amount of 3H-inosine (0.375 
µM) in the medium.    
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Figure 11: Incorporation of guanosine by Coxiella variants.  Purified Coxiella Phase I 
(a; rate shown in exp. 2, Table 2) and Phase II (b; rate shown in exp. 3, Table 2) 
organisms were resuspended in acidic medium supplemented with 40 µCi 3H-guanosine 
and incubated at 37oC.  At times 0, 1, 2, 4, 8, and 16 or 18 hours samples were taken (as 
described in Materials and Methods).  Results are expressed as femtomoles guanosine per 
109 Coxiella. 
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Figure 12: Water space experiments with Coxiella variants.  Purified Coxiella Phase I 
(a) and Phase II (b) organisms (1-4 x 1010 cells) were resuspended in axenic medium (pH 
4.5 or 7.0) supplemented with 40 µM rifampicin, 8 µCi 3H-labeled H2O, and 1 µCi of 
14C-labeled substrate (sucrose, inulin, inosine, adenosine, guanosine, thymidine, cytidine, 
or uridine).  The mixtures were incubated for 1 hour at 37oC and samples were taken and 
processed (as described in Materials and Methods).  The results are expressed as 
cytoplasmic volumes, with 1 equivalent to one cytoplasmic volume.  Each bar represents 
nine individual readings.  Black bars represent organisms resuspended in acidic medium 
(pH 4.5) and gray bars represent organisms resuspended in neutral medium (pH 7.0). 
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Figure 13: Water space examination of guanosine transport.  Purified Coxiella Phase 
I organisms (2.25 x 1010 cells) were resuspended in axenic medium (pH 4.5 or 7.0) 
supplemented with 8 µCi/ml 3H-labeled H2O and 1 µCi/ml 14C-labeled guanosine.  Tubes 
3-9 (bars 3 through 9) contained 40 µM rifampicin. CCCP (final concentration 0.05 mM) 
was added to reaction 5 (bar 5) at time zero, and to reaction 7 (bar 7) at time 40 minutes.  
Unlabeled guanosine (final concentration 20 µM) was added to reaction 6 (bar 6) at time 
zero, and to reaction 8 (bar 8) at 40 minutes.  Reaction 9 (bar 9) received 2 mM KOH (10 
µl per ml reaction) at 40 minutes into the incubation to neutralize the reaction to pH 7.0.  
The final volume for all reactions was 1 ml.  Incubations were carried out for 60 minutes, 
and then samples were removed and processed (as described in Materials and Methods).  
The results are expressed as cytoplasmic volumes, with 1 equivalent to one cytoplasmic 
volume.  Each bar represents three separate reactions from which nine determinations 
were made.  
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Figure 14:  Summary of C. burnetii nucleoside transport.  Active transport 
mechanisms are represented by (A) and heavy black arrows.  Passive transport 
mechanisms are represented by (P) and thin gray arrows.  Compounds not transported 
into the cytoplasm of C. burnetii Nine Mile strain are represented by blocked lines. 
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Abstract 
 Coxiella burnetii is a gram-negative intracellular parasite that resides and 
replicates in a phagosome within its host cell.  As with other obligate intracellular 
bacteria, this organism’s source of nucleotides for energy and polymer synthesis has been 
of interest.  Prior growth experiments in BHK-21 fibroblasts have suggested that the 
avirulent C. burnetii Phase II organism may have an inactive CTP synthase.  Our present 
work focused on the cloning, expression, and characterization of the C. burnetii Nine 
Mile CTP synthase from the wild type and avirulent organisms.  A variety of methods, 
including PCR, DNA sequencing, HPLC, MALDI-TOF mass spectrometry, and UV/Vis 
spectroscopy were employed to examine the CTP synthase gene sequence and protein 
function in C. burnetii Nine Mile Phase I and Phase II variants.  The C. burnetii CTP 
synthase monomer has a theoretical pI of 5.86, a molecular weight of 61,186 Da, and a 
Vmax of 1734 nanomoles of UTP converted to CTP per minute per milligram protein.  
Inhibition studies indicated product inhibition by CTP as well as enzyme sensitivity to 
the inhibitor 6-diazo-5-oxo-L-norleucine.  The C. burnetii Nine Mile Phase I and Phase II 
CTP synthase sequences were compared and found to be identical.  The enzyme is related 
to those found in other γ-proteobacteria, but most closely resembles the Neiserria 
meningitidis enzyme. 
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Introduction 
 Coxiella burnetii is a gram-negative intracellular parasite that is the causative 
agent of Q fever in humans.  The bacterium invades a host cell and enters the acidified 
phagosome to gain access to the environment and metabolic precursors required for its 
replication.  In many infections, C. burnetii causes a mild illness with influenza-like 
symptoms.  However, in some cases, the organism will cause an illness characterized by 
endocarditis that can be hazardous to the patient (Siegman-Igra et al., 1997).  In these 
cases, the patients are given antibiotic regimens that can last for 2 or more years in an 
effort to clear the infection (Calza et al., 2002).  One of the interests of our research 
group is to study phenotype and biochemical differences in C. burnetii variants that could 
be exploited for therapeutic research.  The CTP synthase enzyme in C. burnetii is a 
conserved protein that is a potential target for such research. 
 Studies in both prokaryotes and eukaryotes have shown that CTP synthase 
is a large (~210 kDa) allosteric, homotetrameric enzyme with four identical active sites 
(Levitzki et al., 1971; Levitzki & Koshland, 1972; Long et al., 1970).  Experiments using 
prokaryotic CTP synthases, including Escherichia coli CTP synthase, found that the 
enzyme is influenced by both positive and negative cooperativity in substrate binding 
(Levitzki & Koshland, 1969; Long & Pardee, 1967).  Eukaryote CTP synthase from 
Ehrlich ascites tumor cells or liver cells is influenced less by cooperativity than is the 
bacterial enzyme (Kizaki et al., 1981; Savage & Weinfeld, 1970).  Sedimentation 
equilibrium techniques determined that the native E. coli enzyme equilibrates between 
the monomer, dimer, and tetramer forms (Robertson, 1995).  When ATP and UTP are 
available at saturation concentrations, this enzyme will shift toward the tetramer form 
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(Anderson, 1983; Pappas et al., 1998).  ATP and UTP are also considered effectors of 
positive cooperativity (MacDonnell et al., 2004).  The enzyme amidates a uridine 
triphosphate (UTP) to convert it to cytidine triphosphate (CTP) by utilizing adenosine 
triphosphate (ATP) to phosphorylate the UTP molecule into a 4-phosphorylated UTP 
intermediate (Levitzki & Koshland, 1971; von der Saal et al., 1985).  The NH3 derived 
from the nitrogen donor reacts with the UTP intermediate, completing the reaction 
(MacDonnell et al., 2004).  In intracellular bacteria such as C. trachomatis and R. 
prowazekii, the organism is dependant on the CTP synthase activity for cytidine 
biosynthesis due to their limited transport capability nucleotide synthesis pathways 
(Tipples & McClarty, 1993; Winkler et al., 1999). 
Glutamine is a nitrogen donor (Chakraborty & Hurlbert, 1961), and guanosine 
triphosphate (GTP) initiates allosteric activation (Robertson, 1995) and stabilizes the 
intermediate form of the molecule (Bearne et al., 2001).  In E. coli, GTP acts as a positive 
allosteric effector that increases the enzyme efficiency of glutamine-dependent CTP 
synthesis 45-fold (Iyengar & Bearne, 2003).  GTP can act as a positive or negative 
cooperativity effector, depending on the concentrations of the other substrates 
(MacDonnell et al., 2004).  Magnesium is required in the active site for enzyme function 
(Kizaki et al., 1981; Lieberman, 1956; Robertson & Villafranca, 1993).  Each monomer 
contains a glutamine amide transfer domain (Weng et al., 1986), which catalyses the 
conversion of glutamine to glutamate and NH3 during the reaction (Robertson, 1995).  
The E. coli CTP synthase enzyme will display variable Hill coefficients depending on the 
concentration of the available substrates (Levitzki & Koshland, 1969; Long & Pardee, 
1967) [for example, a UTP Hill plot in the presence of saturating concentrations of ATP 
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(0.65 mM) give a value of 1.3, while lowering the concentration of ATP to non-saturating 
conditions (0.2 mM) will give a Hill value of 2.8] (Long & Pardee, 1967).  Intracellular 
bacteria such as C. trachomatis have been shown to have CTP synthase enzymes that 
display positive cooperativity when UTP was bound in the presence of non-saturating 
concentrations of ATP, however the Hill coefficient value varied (Wylie et al., 1996).  C. 
trachomatis CTP synthase binding of UTP in the presence of saturating concentrations of 
ATP gave Hill coefficient values near 1 (Wylie et al., 1996).  The positive and negative 
cooperativity in the bacterial enzyme can cause each subunit to have subtle 
conformational differences that result in each subunit of the homotetramer having 
differences in substrate affinity (Levitzki & Koshland, 1969; Long et al., 1970).   
Virulent wild-type C. burnetii (Phase I) organisms can transition into avirulent 
variants (Phase II) that display a truncated lipopolysaccharide after repeated passage in 
embryonated eggs (Hoover et al., 2002; Vodkin & Williams, 1986).  In C. burnetii Nine 
Mile strain, a deletion of approximately 26 kb of the chromosome accompanies this 
transition (Hoover et al., 2002).  Growth experiments in our research lab have shown that 
the Phase II variant grows poorly in BHK-21 fibroblasts in 12% CO2 compared to the 
wild type organisms.  We have found that supplementing the growth medium with 1 mM 
cytidine causes a 3-fold increase in Phase II organisms in host cells (Figure 15).  The 
most testable explanation for this cytidine ‘rescue’ effect is that Phase II organisms have 
an inactive CTP synthase due to the phase transition event.   To examine the CTP 
synthase enzyme in C. burnetii variants, the pyrG gene was sequenced from both Phase I 
and Phase II organisms and compared.  Further, C. burnetii cell-free extracts were 
examined for CTP synthase activity by high performance liquid chromatography (HPLC) 
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to identify native enzyme activity in vitro.  The enzyme from the wild-type organism was 
cloned, expressed, and characterized with regard to rate and the effect of various 
inhibitors.  No differences were identified between the C. burnetii Nine Mile Phase I and 
Phase II CTP synthases, either by sequence, enzyme quantitation in cytoplasmic extracts, 
or biochemical activity comparison.  UV/Vis spectroscopy has been employed to 
determine the activity rate of UTP-to-CTP conversion and to measure sensitivity to 
product inhibition and glutamine analogs.  Sequence comparisons with CTP synthases 
from other sources enabled the construction of a minimum evolutionary distance tree. 
 
Materials and Methods 
Biosafety 
All procedures that involved use of viable C. burnetii organisms were performed 
under biosafety level 3 conditions.  Where appropriate, respirator devices were used to 
further protect laboratory personnel from aerosols. 
Bacterial strains and purification methods 
 All cultivation and organism purification methods used were previously described 
(Miller & Thompson, 2002).  In brief, C. burnetii Nine Mile Clone 7 (Phase I) and Clone 
4 (Phase II) were inoculated and cultured in pathogenic-free White Leghorn embryonated 
chicken eggs (SPAFAS Inc., Norwich, CT) until the eggs reached 50% mortality.  The 
yolk sacs were harvested and organisms were purified by homogenization and differential 
centrifugation.  Organisms were centrifuged through sucrose gradients and pelleted.  The 
purified organisms were resuspended in 0.7 M SPG buffer (0.7 M sucrose, 3.7 mM 
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KH2PO4, 6 mM K2HPO4, 0.15 M KCl, 5 mM glutamic acid, pH 7.4) and stored at 4oC 
until use (Miller & Thompson, 2002). 
Cloning and sequencing of the C. burnetii Phase I and Phase II pyrG gene 
 The C. burnetii Nine Mile pyrG gene sequence was amplified by Pfu polymerase 
(Stratagene, La Jolla, CA) from C. burnetii Clone 7 and Clone 4 genomic DNA using 
forward primer CTPSFPSACI (5'-
AATATAGAGCTCATGACACGATATATTTTCATCACC-3') and reverse primer 
CTPSREVKPN3 (5'-AATATAGGTACCTTAGTCCGTTTTTCTGC-3').  The DNA 
fragment was engineered with a SacI site near the pyrG starting methionine and a KpnI 
site at the end of the gene (restriction sites are underlined and C. burnetii-specific DNA 
sequences are italicized).  The PCR products for both of the Phase I and Phase II pyrG 
genes were cloned into the pCR-BluntII TOPO plasmid vector system (Invitrogen, 
Carlsbad, CA) following the manufacturer’s instructions.  Three separate E. coli clones 
containing the Phase I (GA-12, GA-15, GA-29) and Phase II (GA-13, GA-14, GA-19) 
pyrG were isolated, and the resulting plasmids were sequenced separately using 6 
forward primers (FP1: 5'-CTTCGTGCCAATCAACTC-3', FP2: 5'-
CGTGTTTATGCTGATGTA-3', FP3: 5'-GCAGCATTCCGTAAAAGA-3', FP4: 5'-
AAGCCCAGAAAAATCCTC-3', FP5: 5'-CCCTTATTTCGGTATTTG-3', FP6: 5'-
AATGGGGAGACGACTTAG-3') and 6 reverse primers (RP1: 5'-
GTCCCTCCCAAATAATCA-3', RP2: 5'-CCGCTGTTGCTTTAATAT -3', RP3: 5'-
CCAAACAAATACCGAAAT-3', RP4: 5'-CCAGCTCTCCAATCAAGT-3', RP5: 5'-
GCCCCTCCATTCATAACT-3', RP6: 5'-GGGTAGCAACTTTGTAGA-3').  The primer 
pairs were designed from C. burnetii sequence information available from The Institute 
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for Genomic Research (www.tigr.org) (Seshadri et al., 2003).  Primers were generated to 
provide a minimum of 300-bp sequence overlap.  The sequence data for the three Phase I 
CTP synthase clones and the three Phase II sequence clones were compiled separately 
and compared using Omiga software (version 2.0; Accelrys, San Diego, CA). 
HPLC detection of CTP conversion in C. burnetii Nine Mile variant cell-free extract   
C. burnetii Phase I or Phase II organisms purified from 240 g of yolk sac were 
resuspended in 2 ml of 5 mM KH2PO4 and loaded into an Eaton modified press chamber 
(Eaton, 1962).  The organisms were freeze-fractured under 24,000 psi, and the lysate was 
collected and thawed on ice.  The lysate was centrifuged twice at 10,000 x g to remove 
the membrane fraction, and the cell-free (cytoplasmic) lysate was dialyzed in 10,000 MW 
Slide-A-Lyzer cassettes (Pierce Biotechnology Inc. Rockford, IL) for 8 hr in a dialysis 
buffer of 5 mM KH2PO4, pH 7.2, 2 mM glutamine, 5 mM MgCl2, and 70 mM β-
mercaptoethanol (Anderson, 1983; Scheit & Linke, 1982).  The dialyzed lysate was 
removed and stored on ice until use.  
To determine the CTP synthase activity of the cell-free lysate of the two samples, 
870 µl aliquots of Phase I (9.13 mg/ml) or Phase II (6.45 mg/ml) dialyzed cell-free 
extract were added to the dialysis buffer, supplemented with 3 mM ATP, 2 mM UTP, and 
1.5 mM GTP.  This solution was incubated in a 37oC water bath.  At 0, 30, 45, 90, and 
180 sec, 100-µl samples were removed, snap-frozen in a mixture of dry-ice and 95% 
ethanol, and stored frozen at –80oC.  Immediately before HPLC analysis, aliquots of each 
sample were thawed on ice and diluted 1/10 with Buffer A (25 mM ammonium 
dihydrogen phosphate, 1 mM tetrabutyl-ammonium phosphate, pH 7.0) (Bailey et al., 
1990).  Twenty-five microliters of diluted sample was injected into an Ultra-Plus II HPLS 
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(Micro-Tech Scientific, Vista, CA) system equipped with a UV/Vis detector and run 
isocratically on a 1·150-mm reverse-phase column (Zorbax C18 SB 5u 300A, Micro-
Tech Scientific, Vista, CA).  Elution buffer consisted of 95% buffer A and 5% of a 15% 
acetonitrile solution (Bailey et al., 1990) at a flow rate of 100 µl per min.  Effluent was 
monitored at 250 nm.  The column was purged for 30 min following each injection to 
remove residual protein and nucleic acids.  Data acquisition and sample analyses were 
performed by Chrom. Perfect Spirit, version 5.1 (Justice Laboratory Software, Denville, 
NJ).  Peak identities were verified both by comparison of retention times to standards and 
by absorbance spectra from 225-300 nm using a Genespec III spectrophotometer and 50-
µl quartz cuvettes ( both from MiraiBio, Alameda, CA).  
Quantitation of CTP synthase in Phase I and Phase II cytoplasmic lysates  
 Equal quantities (5 µg and 10 µg) of Phase I and Phase II cytoplasmic lysate were 
separated on a 10% SDS polyacrylamide gel and transferred to nitrocellulose, along with 
10, 5, 1, 0.5, and 0.1 nanograms of recombinant CTP synthase as quantitation standards.  
The nitrocellulose was probed with rabbit polyclonal α-C. burnetii CTP synthase sera 
and detected using the SuperSignal West Pico Chemiluminescent kit (Pierce 
Biotechnology Inc. Rockford, IL).  Digital images were captured on an Alphainnotech 
FluorChem 8800 (Alpha Innotech Corporation, San Leandro, CA).  Densitometric 
analysis was performed using Alpha Easy software (Alpha Innotech Corporation, San 
Leandro, CA).  Images analyzed were below saturation levels.   
Expression and rate determination of histidine-tagged C. burnetii CTP synthase 
 The cloned C. burnetii Phase I pyrG from pGA29 was removed using SacI and 
KpnI restriction enzymes (Promega, Madison, WI).  The DNA fragment was ligated into 
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the pBAD/His A plasmid (Invitrogen, Carlsbad, CA) following the manufacturer’s 
protocol.  After transformation, E. coli clones were screened using 100 µg/ml ampicillin 
and PCR-verified using the FP4 and RP4 primer set.  The resultant clone (GA-31) was 
grown in Luria-Bertani broth with 100 µg/ml of ampicillin at 37oC to an OD600 of 0.6 
absorbance units, and 0.02% arabinose was added to induce protein production.  After 5 
hr of incubation at 37oC in a shaking incubator, the cells were harvested, washed in PBS, 
pH 7.2, and resuspended in 2 ml of Probond native binding buffer (Invitrogen, Carlsbad, 
CA).  In an effort to stabilize the enzyme and prevent protein degradation, 0.5 mM 
glutamine, 10 mM MgCl2, 0.5 mM EDTA, 1 mM ATP, 1 mM UTP, and protease 
inhibitor cocktail (2 µg/ml leupeptin, 1 µg/ml aprotinin, 1 µg/ml pepstatin A [Sigma 
Chemical Co., St. Louis, MO]; and 24 µg/ml of Pefabloc SC [Roche Applied Science, 
Indianapolis, IN]) was added to all Probond buffer solutions (binding, wash and elution 
buffer, Invitrogen, Carlsbad, CA).  The induced GA-31 clone was transferred into a 
modified Eaton press chamber (Eaton, 1962) pre-chilled to –80oC, and placed under 
24,000 psi until organisms fractured.  The resultant lysate was thawed on ice and loaded 
onto a column containing Probond Ni-beads (Invitrogen, Carlsbad, CA).  Hexahistidine-
tagged CTP synthase was eluted from the Probond beads as recommended by the 
manufacturer.  The enzyme was quantitated by BCA protein assay (Pierce Biotechnology 
Inc., Rockford, IL) and frozen at –20oC at a concentration of 1 mg/ml in a freezing 
solution containing 0.2 M HEPES buffer, pH 8.0, 20% glycerol, 10 mM MgCl2, 1 mM 
EDTA, 2.5 mM ATP, 2.5 mM UTP, and 70 mM β-mercaptoethanol (Anderson, 1983) at 
–20oC.   
 105
 The C. burnetii recombinant CTP synthase amino acid sequence was examined by 
use of MALDI-TOF mass spectrometry.  One microgram of the hexahistidine-tagged 
CTP synthase monomer was loaded and separated on a 10% SDS polyacrylamide gel.  
The protein was visualized with Gelcode Blue stain (Pierce Biotechnology Inc., 
Rockford, IL) and excised.  The isolated protein was treated as described elsewhere 
(Fountoulakis & Langen, 1997; Lamer & Jungblut, 2001), and the tryptic digest pattern 
was determined by matching the mass fingerprint determined by a Reflex IV Matrix-
Assisted Laser Desorption Ionization Time-of-Flight (MALDI-TOF) Mass Spectrometer 
(Bruker Daltonics, Inc., Billerica, MA) to a theoretical fingerprint using MS-Digest 
software developed by Peter Baker and Karl Clauser (http://prospector.ucsf.edu).  The 
protein amino acid sequence matched the theoretical amino acid sequence for the C. 
burnetii CTP synthase (44% coverage). 
Sequence comparison of CTP synthase enzymes 
 The amino acid sequence of the C. burnetii CTP synthase was compared and 
aligned with sequences from 13 other organisms that survive in various environmental 
conditions (Bacillus subtilis, Chlamydia trachomatis, E. coli O157:H7, Haemophilus 
influenzae, Methanothermobacter thermautotrophicus, Neiserria meningitidis, 
Pseudomonas aeruginosa, Saccharomyces cerevisiae (URA7), Salmonella enterica, 
Synechocystis sp., Thermosynechococcus elongatus, Vibrio cholerae, and Yersinia 
pestis).  The sequences were aligned using Omiga software (version 2.0; Accelrys, San 
Diego, CA).  The amino acid sequences were also compared using Phylogenetic Analysis 
Using Parsimony (PAUP) software (version 4.0b10, David Swofford, Sinauer Associates, 
Sunderland, MA).  PAUP trees were constructed using full heuristic searches, 100 
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bootstrap replicates, and parsimony and minimum evolutionary distance for optimality 
criteria.     
Enzyme Kinetics 
CTP conversion experiments were done in triplicate as described by Anderson 
(Anderson, 1983).  In brief, hexahistidine-tagged CTP synthase was thawed and stored on 
ice.  Aliquots of 10-µg CTP synthase (unless specified otherwise) were added to a 
reaction mixture consisting of 1 mM ATP, 1 mM UTP, 0.2 mM GTP, and pre-warmed 
(37oC) reaction buffer (0.06 M HEPES, pH 8.0, 0.5 mM EDTA, 0.01 M glutamine, 0.01 
M MgCl2, and protease inhibitor cocktail) at a final volume of 1 ml.  Reaction mixtures 
were added to pre-warmed (37oC) matched quartz cuvettes (Fisher Scientific, Suwanee, 
GA).  The absorbance of the sample at OD291 was recorded at one minute intervals using 
a Beckman Coulter DU 7500 spectrophotometer (Beckman Coulter, Fullerton, CA).  
Reaction mixtures were added to pre-warmed (37oC) matched quartz cuvettes (Fisher 
Scientific, Suwanee, GA).   The rate of CTP production was calculated from the slope of 
the absorbance versus time data (corresponding to the first 5 minutes) using the 
extinction coefficient (∆ε = 1338 M-1·cm-1) (Bearne et al., 2001), and was expressed as 
nanomoles CTP per minute per milligram enzyme protein.  Background was corrected by 
using blank reaction mixtures without 1 mM UTP added.  The CTP synthase kinetic 
parameters were determined by measuring the enzyme velocity at various concentrations 
of UTP in the reactions (0.001 mM, 0.01 mM, 0.1 mM, 0.25 mM, 0.5 mM, 1.0 mM, and 
2 mM).  The velocity versus substrate data was fitted to a hyperbolic curve using the 
program KFIT written by N. C. Millar, which provided the Vmax and the Km values.  The 
results were plotted by using Sigma Plot 2001 (SPSS, Inc., Chicago, IL).   
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Inhibition experiments were carried out using the CTP synthase inhibitors CTP 
and 6-diazo-5-oxo-L-norleucine [DON] (Sigma Chemical Co., St. Louis, MO).  CTP 
synthase activity was assayed at 1 mM UTP to ensure the enzyme was operating at 
maximum velocity.  Either CTP or DON was added to the reaction mixture prior to the 
addition of enzyme at concentrations of 0.1, 0.25, 0.5, 1, and 2 mM, with reaction 
volumes remaining at 1 ml.  CTP synthase activity was measured as described above.  
Negative control experiments were established by denaturing hexahistidine-tagged CTP 
synthase at 95oC for 15 min (heat-inactivated).  Inhibition data were graphed by using 
Sigma Plot 2001 (SPSS, Inc., Chicago, IL).   
 
Results 
Cloning and comparison of the Phase I and Phase II pyrG genes   
The C. burnetii Phase I and Phase II variant CTP synthase (pyrG) genes were 
cloned from genomic DNA.  Each primer set used in DNA sequencing was designed to 
give at least 300-bp of overlapping sequence to ensure redundancy and avoid misread 
sequences.  The consensus sequence from the Phase I and Phase II pyrG genes were 
compared and found to be identical (data not shown).  To ensure that no point mutations 
were present immediately before or after the Phase II gene, 300-bp regions before (5') 
and after (3') the C. burnetii Nine Mile Phase I and Phase II pyrG genes were amplified, 
sequenced, and compared.  No differences were found in the sequence analyses (data not 
shown). 
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HPLC determination of CTP synthase activity in C. burnetii cell-free extract 
Function of the enzyme within the lysates of phase variants was examined in 
greater detail.  Concentrated C. burnetii Phase I and Phase II cell-free lysates were 
dialyzed with substrates to give the enzyme greater stability.  The UTP-to-CTP 
conversion reactions were allowed to proceed for set times, after which the reaction 
mixture was immediately snap-frozen to keep the nucleotide triphosphates from 
hydrolyzing to di- or monophosphate forms.  Samples were subjected to HPLC to 
determine conversion of UTP to CTP (Figures 15a & b).  A clearly resolved peak 
corresponding to the presence of CTP appeared in every time point for both Phase I and 
Phase II organisms, as determined by the retention time of a CTP standard.  In addition to 
the CTP peak, the UTP, GTP, and ATP peaks were verified by both the retention time of 
standards and their absorbance spectra (225 to 300 nm).  The data indicate that both C. 
burnetii organisms have fully functional CTP synthase enzymes within their cytoplasmic 
fractions.   
Quantitation of CTP synthase in Phase I and Phase II cytoplasmic lysate 
 To determine if Phase I and Phase II organisms have similar concentrations of 
CTP synthase, four separate nitrocellulose protein blots were prepared with duplicate 
protein samples of Phase I and Phase II cytoplasmic lysates.  Each protein blot was 
probed using rabbit α-C. burnetii CTP synthase and bands were detected using 
chemiluminescence.  Band densities were converted to picograms protein concentration 
by comparison to known standards (10, 5, 1, 0.5, 0.1 ng) of recombinant hexahistidine-
tagged C. burnetii CTP synthase placed on each blot.  It was found that 5 µg of Phase I 
and Phase II cytoplasmic lysate contain equal concentrations of CTP synthase (Phase I = 
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217 ± 34 pg, Phase II = 206 ± 32 pg) (Figure 16).  Further, no size difference was 
apparent between the Phase I and Phase II CTP synthase band, suggesting that the Phase 
II enzyme is not inactivated by degradation.     
Hexahistidine-tagged C. burnetii CTP synthase expression and activity   
The cloned recombinant hexahistidine-tagged CTP synthase monomer amino acid 
sequence was confirmed by MALDI-TOF mass spectrometry (data not shown).  The 
calculated molecular weight of the monomer is 61,186 Da with a theoretical pI of 5.86 
(ExPASy [Expert Protein Analysis System] Swiss Institute of Bioinformatics; 
http://us.expasy.org).   
 The recombinant enzyme was purified and assayed for CTP synthase activity in 
triplicate from three separate enzyme preparations and compared.  Assays were 
performed at saturating UTP levels according to Anderson (Anderson, 1983).  Before 
purification, the induced E. coli (GA-31) lysate had a UTP-to-CTP conversion rate of 34 
nmol/min per mg total lysate protein.  Once purified, the enzyme gave a UTP-to-CTP 
conversion rate of 1607 ± 54 nmol/min per mg enzyme protein (n=12) (data not shown).  
To verify that the enzyme was operating at maximum velocity, a new preparation of 
enzyme was assayed at various concentrations of enzyme (from 1 to 20 µg), and the 
resulting activity was found to be linearly dependent on enzyme concentration (Figure 
18).  As a negative control, heat-inactivated CTP synthase was assayed and found to have 
a negligible activity (16 ± 12 nmol/min per mg enzyme protein; n = 3), indicating that the 
increase in the observed absorbance in the experimental samples is due to the enzyme 
activity, not its impurities in the reaction mix or non-enzymatic nucleotide conversion.   
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Batch-to-batch rates of the CTP synthase enzyme were consistent whether they were 
frozen (-20oC) or used immediately after purification. 
To determine the kinetic constants for the recombinant CTP synthase, UTP-
dependent enzyme activity was assayed at various concentrations of UTP (from 0.001 to 
2 mM) (Figure 17).  The resulting data was hyperbolic, which indicated a maximum 
velocity of the enzyme at 1734 nmol/min per mg enzyme protein.  The enzyme was 
determined to have a Km of 0.123 mM and a Hill coefficient of 1.05 for UTP when the 
other substrates were present in saturating concentrations.  The experiment was 
performed in triplicate to ensure reproducibility.   
To determine whether the accumulation of product has an effect on the 
recombinant enzyme, the concentration of CTP in the reaction mixtures was increased 
over a range from 0.1 to 2 mM.  When 0.5 mM and 2 mM CTP were added to the 
reaction mixtures, the enzyme activity was inhibited by 62% and 95%, respectively 
(Figure 19).  DON, a glutamine analog and known CTP synthase inhibitor (Robertson, 
1995), inhibited the C. burnetii CTP synthase by 59% at a concentration of 0.25 mM in 
the reaction and by 94% if 1 mM was used (Figure 19).   
Sequence alignment of CTP synthase enzymes 
The C. burnetii CTP synthase protein monomer is composed of 555 amino acids, 
has a molecular weight of 61,224 Da (ExPASY; http://us.expasy.org ), and has a 
theoretical pI of 5.86.  All CTP synthase enzymes have structural components, such as 
nucleotide binding sites, in common that are required for their activity.  As determined on 
the basis of its amino acid sequence, the C. burnetii CTP synthase monomer has a region 
with a high identity to glutamine amidotransferase domains (amino acids 302-532; amino 
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acids 324-572 in Figure 20) from both eukaryotic and prokaryotic organisms (NCBI 
BLAST, www.ncbi.nlm.nih.gov/BLAST/).  It also has an amino acid sequence (amino 
acids 145-157; amino acids 156-168 in Figure 20) that is identical to a putative CTP 
nucleotide-binding site in E. coli (amino acids 146-158; amino acids 156-168 in Figure 
20) (Simard et al., 2003).  This amino acid region also shows high identity to other CTP 
synthase sequences when compared by use of an alignment tool (amino acids 152-169, 
Figure 20).  The alignment software also identified regions of either amino acid 
consensus identity or consensus matches that would suggest sequences important for 
enzyme activity or structural integrity (Figure 20).  The C. burnetii CTP synthase has an 
overall identity of 65% compared with the E. coli enzyme and an identity of 50.7% with 
the C. trachomatis enzyme, another intracellular parasite that lives in a different type of 
parasitophorous vesicle within the host cell.   
CTP synthase PAUP trees 
When PAUP trees were constructed using CTP synthase amino acid sequences 
from all 14 organisms, it was found that the C. burnetii (a γ-proteobacterium) CTP 
synthase enzyme was most related to the N. meningitidis (a β-proteobacterium) enzyme 
(Figure 21).  The alignment of C. burnetii and N. meningitidis CTP synthase amino acid 
sequences have an identity score of 66%, which was the highest identity score found 
using BLAST software (www.ncbi.nlm.nih.gov/BLAST/).  Dendograms constructed 
using either minimum evolution distance or parsimony both paired these enzymes 
together.  The C. burnetii sequence also clusters closely with the other γ−protobacteria 
assembled in the tree, lending confidence to the analysis.   
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Discussion 
 C. burnetii Nine Mile strain Phase II organisms have a 26-kb deletion in the 
chromosomal DNA (Hoover et al., 2002).  This deletion, which contains primarily O-
antigen synthesis genes, explains many of the characteristics of Phase II 
lipopolysaccharide when compared with those of the Phase I wild-type [see also (Miller 
& Thompson, 2002)].  However, other known phenotype differences between the phase 
variant and the wild-type could be due to smaller deletions or mutations in other areas of 
the genome that have not been characterized.  To determine if the inhibition was caused 
by a genetic mutation or deletion, the CTP synthase genes in both Phase I and Phase II 
organisms were sequenced. 
Sequencing the C. burnetii pyrG gene from the chromosomes of both the Phase I 
and Phase II variants have shown that the gene sequence is identical in both organisms.  
To demonstrate that the CTP synthase enzyme was active in both Phase I and Phase II 
organisms, we used cell-free lysate and HPLC to show the in vitro conversion of UTP to 
CTP (Figure 15).  This method, while excellent for identifying the presence of CTP, 
could not be used to determine the specific activity of the CTP synthase due to the 
amount of nucleotides retained in the column.  We had to rely on the recombinant CTP 
synthase enzyme to determine UTP-to-CTP conversion activity.  We could not identify 
differences between Phase I and Phase II variant CTP synthase by gene sequence, protein 
concentration, subunit size, or the enzyme activity in the conditions examined.   
Cytidine plays an important role in the biochemistry of an organism as one of the 
building blocks of DNA and RNA, and also in LPS biosynthesis (Pazzani et al., 1993; 
Raetz, 1990; Roberts, 1996).  Organisms must have methods for acquiring cytidine, either 
 113
by de novo synthesis or by transport mechanisms.  Coxiella burnetii can incorporate 
radiolabeled cytidine into macromolecules, probably by passive or facilitated diffusion 
(Miller & Thompson, 2002).  Our current work characterizes the activity of the C. 
burnetii CTP synthase.  
When enzyme activities are compared, the recombinant C. burnetii CTP synthase 
has a lower Km (0.123 mM) than the reported E. coli CTP synthase activity (0.29 ± 0.04 
mM) (Bearne et al., 2001).  The C. burnetii recombinant enzyme also showed a lower 
Hill coefficient for UTP under saturating ATP concentrations than found for the E. coli 
enzyme under the same conditions [1.05 and 1.3, respectively (Long & Pardee, 1967)].  
This suggests that the C. burnetii CTP synthase enzyme is less positively affected by 
binding UTP to its active site than the E. coli CTP synthase enzyme.  In unsaturated ATP 
conditions, the Hill coefficient for UTP increases to 2.8 (Long & Pardee, 1967).  It is 
unknown whether the C. burnetii CTP synthase enzyme would display greater positive 
cooperativity to binding UTP in its active site when ATP is present in lower 
concentrations.   The C. burnetii recombinant CTP synthase exhibits a UTP-to-CTP 
conversion rate of 1607 ± 54 nmol/min per mg enzyme protein.  This rate is three to five 
times lower than the reported E. coli CTP synthase specific activity of between 5.8 and 
8.7 µmol of CTP/min per mg protein reported previously (Bearne et al., 2001), however 
C. trachomatis, another intracellular bacteria, has a similar measured UTP-to-CTP 
conversion rate (Wylie et al., 1996).  Considering that the C. burnetii replication time is 
between 12 and 20 hr (Maurin & Raoult, 1999; Zamboni et al., 2002), its demand for 
CTP may be lower than that of more rapidly growing organisms, such as E. coli.  It is 
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also possible that the in vitro rate of the C. burnetii CTP synthase may be higher than the 
rate of the enzyme in vivo, which could vary depending on the conditions in the host cell.   
Efforts were made to remove the hexahistidine tag from the recombinant enzyme 
by enterokinase cleavage, but no buffer conditions could be identified to allow for the 
enterokinase activity while keeping the CTP synthase enzyme stable.  Further, the long 
digestion times at 37oC further complicated efforts to stabilize the enzyme.  In the future, 
native CTP synthase enzyme could be purified from cell-free extracts using 
immunoprecipitation techniques to provide a nearly pure enzyme preparation.  However, 
this method could also lead to enzyme degradation due to the pH changes required to 
remove the enzyme from the antibodies.  Other researchers have investigated whether 
CTP synthase activity changes in the presence or absence of hexahistidine tags and have 
identified no UTP-to-CTP conversion rate differences between hexahistidine-tagged and 
native CTP synthase enzymes (Bearne et al., 2001). 
 Regulation of CTP synthase enzymes in other organisms was reviewed to see if C. 
burnetii is regulated in a similar manner.  The C. burnetii CTP synthase, like other 
bacterial CTP synthase enzymes, displays product inhibition, exhibiting nearly complete 
inactivation in the presence of 2 mM CTP (Figure 19).  Gram-positive bacteria have 
exhibited regulation at the RNA level by a hairpin sequence before (5') the CTP synthase 
gene (Meng & Switzer, 2001; Meng & Switzer, 2002).  A similar sequence motif could 
not be identified 5' to the C. burnetii CTP synthase gene.  The yeast S. cerevisiae is 
regulated by phosphorylation of serine residues (Choi et al., 2003; Park et al., 2003; 
Yang & Carman, 1996).  The C. burnetii CTP synthase enzyme does not have the same 
serine residues that regulate the yeast enzyme (Figure 20).  It is unknown if the C. 
 115
burnetii CTP synthase is regulated by phosphorylation, but it must remain a possibility.  
Other forms of regulation may play a role in the C. burnetii CTP synthase activity, but 
the mechanism has yet to be discovered.   
 The C. burnetii CTP synthase does display sensitivity to the glutamine analog 
DON.  We have demonstrated that 10 µg of recombinant CTP synthase is more than 90% 
inhibited in the presence of 0.5 mM DON (Figure 19).  The inhibition concentration of 
DON is much lower than the concentrations required for CTP to inhibit enzyme activity.  
In E. coli, DON is thought to inhibit enzyme activity by entering the enzyme active site 
and causing the tetramer to dissociate into dimers, disrupting normal enzyme function 
(Robertson, 1995).    Thus, lower concentrations of DON show greater effect than 
competitive inhibitors such as CTP due to the dissociation effect on the tetrameric 
enzyme.  If more dilute concentrations of DON were used in the experiments, the shape 
of the inhibition curves would more closely resemble the slower activity drop-off 
observed in the CTP inhibition experiments (Figure 19).  A question of the effect of the 
hexahistidine tag of the recombinant CTP synthase enzyme on inhibition must remain 
unanswered.  While the presence of the tag has not shown any effect on enzyme activity 
on the E. coli recombinant CTP synthase enzyme (Bearne et al., 2001), no studies have 
been performed examining the effect of the hexahistidine tag on the availability of the 
active site to inhibitory chemicals.  
 CTP synthase is a target in the development of anti-viral (De Clercq, 1993; Gao et 
al., 2000) and anti-protozoal (Hofer et al., 2001; Lim et al., 1996) therapies.  C. burnetii 
endocarditis, caused by C. burnetii organisms entering damaged heart valve tissue and 
causing pathology in the infected area (Lepidi et al., 2003), comprises 1-16% of all 
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reported Q fever cases (Siegman-Igra et al., 1997).  The current treatment of Q fever 
endocarditis requires that patients receive antibiotics, such as doxycycline and 
hydroxychloroquine, for periods up to 2 years (Calza et al., 2002).  Because C. burnetii 
Phase I and Phase II organisms did not concentrate pyrimidine nucleosides in its 
cytoplasm in transport assays in vitro (Miller & Thompson, 2002), it is possible that C. 
burnetii cannot actively transport cytidine in situ, but it is permeable to it.  Because of the 
limited transport of cytidine, it may be vulnerable to DON therapy or other analogous 
inhibitors used to eliminate de novo cytidine synthesis.  This method is currently being 
investigated for the treatment of Trypanosoma brucei, the causative agent of African 
sleeping sickness (Hofer et al., 2001), and may have application to Q fever endocarditis.    
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Figure 15:  UTP to CTP conversion using C. burnetii phase variant cell-free extracts.  
Phase I (9.13mg/ml) (Figure A) and Phase II (6.45mg/ml) (Figure B) concentrated cell-
free extracts were used to examine native CTP synthase activity.  Nucleotides were 
detected at OD250 by use of a flow cell UV/Vis spectrometer.  Nucleotide triphosphate 
peaks are labeled.  The x-axis is retention time and the y-axis is mV response. 
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Figure 16: Western blot of Phase I and Phase II cytoplasmic lysates.   
Chemiluminescent detection of 5 µg samples of Phase I (Lane 1) and Phase II (Lane 2) 
cytoplasmic lysate transferred onto nitrocellulose with 1 ng (Lane 3) and 500 pg (Lane 4) 
concentrations of purified recombinant C. burnetii hexahistidine-tagged CTP synthase.  
Samples were probed with polyclonal rabbit α-C. burnetii CTP synthase sera.
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Figure 17:  UTP to CTP conversion rate of C. burnetii CTP synthase.  The closed 
circle represents the amount of CTP converted by 10 µg recombinant CTP synthase.  
Each point was conducted in triplicate.  Error bars represent SD.  The x-axis is mM UTP 
and the y-axis is the nanomoles CTP detected per minute per milligram enzyme protein at 
OD291.  
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Figure 18: Linear dependence of C. burnetii CTP synthase.  UTP-to-CTP conversion 
of varying concentrations of recombinant hexahistidine-tagged C. burnetii CTP synthase 
(from 1 µg to 10 µg) was observed over a 10 minute time frame.  Each point represents 
three separate experiments.  The x-axis is time reported as minutes and the y-axis is the 
nmol CTP converted per minute per milligram enzyme protein at OD291.  Error bars are 
reported as SD.  CTPS = CTP synthase
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Figure 19:  Inhibition of recombinant CTP synthase, using DON and CTP.    Each 
point represents the activity of 10 µg of recombinant C. burnetii CTP synthase.  The 
closed circles represent activity in the presence of various concentrations of DON.  The 
open circles represent activity in the presence of CTP.  Each point represents three 
separate experiments.  The data are displayed as percent activity of enzyme, with 100% 
activity being equal to 1599 ± 96 nmol CTP/min per mg enzyme protein.  The x-axis 
represents mM inhibitors introduced into the reactions.  The y-axis is the percent activity 
of recombinant C. burnetii CTP synthase.  Error bars are reported as SD. 
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Figure 20: Alignment of CTP synthase sequences.  The amino acid sequences of 14 
CTP synthase enzymes were compiled and aligned by use of Omiga (version 2.0; 
Accelrys, San Diego, CA).  The organisms used in the alignment were, respectively,  
B. subtilis, C. burnetii, C. trachomatis, E. coli O157:H7, H. influenzae,  
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V H E R H R H R Y E I N P K M V D E L E N N G L I F V G K D D T - G K R C E I L E L K N H P Y Y I A T Q Y H P E Y T S K V L D P S K P F L G L V A A S A G I L Q D V I E G K Y D L E A G E N K F N F
I V E R H R H R Y E V N N M L L K Q I E A A G L R V A G R S G D - D Q L V E I I E V P N H P W F V A C Q F H P E F T S T P R D G H P L F A G F V K A A N E H Q K R Q A K
V Y E R H R H R Y E F N N S Y R T Q F T D T G F V V S G T S P D - G R L V E I V E Y P H H P F F I A C Q F H P E F H S R P N Q A H P L F S G F I N A V L K R R N A P A K I A V N C H T V T E D H E P S
I Y E R H R H R Y E F N N A Y R N L F L E T G Y Q I T G T S P D - G R L V E I I E Y P A H P F F I A V Q F H P E F R S R P N A P H P L F Y G L L A A A A K N S N R D H P Q L V P S F
I H E R H R H R Y E V N N L L R P Q I E K A G L K V S G L S A D - K K L V E V I E N P A H P W F V A A Q F H P E F T S T P R D G H P L F A G F V K A A G Q F Q R G E L K
I V E R H R H R Y E V N N M L L K Q I E A A G L R V A G R S A D - N K L V E I I E L P D H P W F V A C Q F H P E F T S T P R D G H P L F A G F V K A A G D Y Q K R Q V K
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M. thermautotrophicus, N. meningitides, P. aeruginosa, S. cerevisiae, S. enterica, 
Synechocystis sp., T. elongatus, V. cholerae, and Y. pestis.  Dark gray shading signifies 
sequence consensus identity.  Light gray shading represents a sequence consensus match 
(≥ 60% identity). 
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Figure 21: Dendogram of CTP synthase enzymes.  The amino acid sequences of the 
CTP synthase enzymes of 14 prokaryote and eukaryote organisms were analyzed, using 
PAUP version 4.0b10.  The tree was constructed using the optimality criterion of 
minimal evolutionary distance with 100 bootstrap replicates using a full heuristic search.  
The numbers on the tree represent the bootstrap replicates.  The distance measure used is 
the mean character distance. 
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General Discussion 
 
C. burnetii Phase I and Phase II growth in BHK-21 cells 
Our research in C. burnetii Nine Mile nucleoside metabolism and transport was 
initiated by preliminary evidence that extracellular cytidine influenced and ‘rescued’ 
Phase II variant growth in BHK-21 host cells cultured at 12% CO2.  This observation was 
examined in more detail using BHK-21 host cells infected with low MOI of wild type 
(Phase I) and avirulent (Phase II) organisms either untreated, supplemented with 1 mM 
cytosine, or supplemented with 1 mM cytidine.  The organisms were carefully 
enumerated in stained BHK-21 cells, and the results showed that Phase II organisms that 
were untreated or supplemented with 1 mM cytosine did not show any growth 
improvement (Figure 6b).  If the Phase II growth trend in those tissue culture systems had 
been allowed to continue for a longer period of time, the organisms in those cultures 
would probably have perished.  In contrast, the Phase II organisms cultured with 1 mM 
cytidine in their growth medium displayed a significant improvement in their replication 
in host cells.  This improvement continued for 20 days, and was statistically significant 
when compared to the other Phase II growth conditions (Figure 6b).  The cytidine-
supplemented Phase II growth data resembles Phase I growth data when compared by 
landscape graphs (Figures 9a & 9b).  These results suggest that cytidine supplementation 
restores some portion of Phase II growth ability; however the exact reason for this growth 
response remains unknown.  One possibility is that the ribose sugar could be dissociated 
from the cytidine molecule, giving the bacteria another carbon source that could explain 
the cytidine growth effect.  This explanation is less believable, however, due to ring-
labeled and ribose sugar-labeled thymidine incorporation experiments.  When the 
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incorporation rates were compared between the ring-labeled thymidine and the ribose-
labeled thymidine synthesized into acid-insoluble macromolecules, no differences in 
incorporation were observed (data not shown).  If the ribose sugar was being cleaved 
from the thymidine molecule to be used as a carbon source, a difference in radiolabeled 
compound should have been observed.  While this experimental observation does not 
eliminate the possibility that the dissociated ribose from the cytidine molecule is the 
cause of the growth effect, it makes it much less probable.    While there are a plethora of 
other possible explanations for the growth improvement in host cells, the most testable 
hypothesis was that the CTP synthase enzyme, the enzyme responsible for de novo 
synthesis of CTP in bacteria, was inactivated or inhibited. 
Transport of nucleosides 
 While growth experiments exhibited improved Phase II replication in BHK-21 
cells in the presence of 1 mM cytidine, it was unknown if C. burnetii could transport 
cytidine.  All transport and incorporation experiments were performed on wild type 
organisms in acidified media.  It was questioned whether Phase II organisms displayed 
the same transport capability due to the fact that the avirulent organisms have truncated 
lipopolysaccharides on their outer membrane.  This exposes protein charges of the outer 
membrane to the extracellular environment (Hackstadt, 1990), potentially playing a role 
in repelling nucleosides from the outer membrane and making the nucleoside transport 
mechanisms less efficient than wild type transport mechanisms.  Another consideration 
was that phase transition adversely affects transporter mechanisms by deletion or 
modification.  To investigate these possibilities, Phase I and Phase II organisms were 
isolated, purified, and transport mechanisms investigated by the use of radiolabeled 
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nucleobases, nucleosides, and various nucleotides in acidified medium.  It was discovered 
that nucleosides, not nucleotides or nucleobases, are transported and incorporated into 
Phase I and Phase II acid-insoluble macromolecules (Table 2; Figure 14).  Further, water 
space experiments demonstrate that purine nucleosides are concentrated in the cytoplasm 
of both Phase I and Phase II organisms, which indicate active transport mechanisms 
involved in purine transport (Figures 12a & 12b).  Water space assays also indicate that 
pyrimidine nucleosides are not concentrated in C. burnetii cytoplasm, specifying passive 
or facilitated diffusion (Figures 12a & 12b).  Both transport and water space experiments 
support the position that Phase II organisms can transport and utilize cytidine if it is 
available in the extracellular environment, assuming that the C. burnetii organism is in an 
acidic environment when cytidine is present.   
 The water space data does suggest a difference in purine nucleoside concentration 
between Phase I and Phase II organisms (Figures 12a & 12b).  Both inosine and 
adenosine nucleosides appear to be more concentrated in Phase I organisms than Phase II 
organisms.  Guanosine concentration does not appear to be affected by phase transition.   
Guanosine transport and water space experiments exhibited another significant 
finding; that C. burnetii Phase I organisms transport and incorporate guanosine 
nucleosides at neutral pH.  This is surprising because it has never been shown that C. 
burnetii displays any biochemical activity at neutral pH, but was assumed to be inert until 
it reached the acidic environment of the host cell phagosome.  It may be that guanosine 
incorporation occurs as a form of priming, preparing the organism for active metabolism 
and replication processes while it is between host cells.  Another possibility is that 
guanosine may be synthesized into RNA chains as a response to stress (such as being 
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released by host cell lysis).  The stored guanosine would then be utilized in conjunction 
with inorganic polyphosphate chains as energy when the organism returns to an 
environment suitable for replication (Kim et al., 2002; Rao & Kornberg, 1996; Rao & 
Kornberg, 1999). 
Gene sequence analysis of Phase I and Phase II CTP synthase 
 A possible explanation for the observed Phase II CTP synthase inactivity was that 
gene deletions or point mutations interfered with the normal enzyme activity.  Three 
plasmid clones of Phase I or Phase II pyrG were constructed and sequenced.  Once the 
genetic sequences were aligned and compared, no sequence variations or anomalies were 
apparent between the wild type and avirulent pyrG genes.  The DNA sequences 5′ and 3′ 
to the pyrG gene were also sequenced, and found to be identical.  We had to conclude 
that the enzyme activity differences were not due to a difference in genetic sequence. 
Proteomic investigation of the CTP synthase enzyme 
 Since the gene sequence of the Phase I and Phase II pyrG were identical, other 
protein-based methods were utilized to determine if any differences between the CTP 
synthase enzymes could be identified.  The cloning and production of a recombinant 
hexahistidine-tagged C. burnetii CTP synthase protein was completed (see 
Characterization of CTP synthase from the Coxiella burnetii Nine Mile Strain).  Samples 
of the recombinant protein were injected into rabbits to generate C. burnetii-specific 
polyclonal α-CTP synthase serum.  The polyclonal antibodies were used to probe equal 
concentrations of Phase I and Phase II cytoplasmic lysate to compare and quantitate the 
CTP synthase monomers.  There were no observable differences in protein size when the 
CTP synthase bands were compared (Figure 17).  Further, protein quantitation by 
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densitometry determined that Phase I and Phase II cytoplasmic lysates contain roughly 
identical concentrations of CTP synthase monomer (Figure 17).  These experiments 
indicate that Phase I and Phase II organisms have identical concentrations of CTP 
synthase enzyme in their cytoplasm.   
 To investigate whether the Phase II cytoplasm might contain inhibitory 
compounds or protein fragments to impede CTP synthase activity, mixing experiments 
were performed by adding varying concentrations of Phase I and Phase II cytoplasmic 
lysates to reaction mixtures containing 10 µg of recombinant hexahistidine-tagged CTP 
synthase (Table 1).  The experiment showed that neither Phase I or Phase II cytoplasmic 
lysates inhibited or interfered with the reaction rate of recombinant CTP synthase.  The 
results suggest that the Phase II cytoplasm does not contain an inhibitory substance that 
would affect the activity of the CTP synthase enzyme.  It may be that inhibition was not 
observed due to steric hinderance caused by the recombinant CTP synthase hexahistidine 
tag blocking the active site.  This possibility has not been examined at this time, however 
steric hinderance due to the hexahistidine tag or differences in UTP-to-CTP conversion 
rates have not been observed in activity studies using the E. coli hexahistidine-tagged 
recombinant CTP synthase enzyme (Bearne et al., 2001). 
HPLC examination of Phase I and Phase II cytoplasmic lysates 
Due to the sequence and protein data exhibiting no variation between the Phase I 
and Phase II CTP synthase enzymes, the activity of cytoplasmic lysates were reexamined. 
High Performance Liquid Chromatography (HPLC) was selected as a detection method 
due to its sensitivity and ability to detect nucleotides in a complex mixture.  Phase I and 
Phase II lysates were utilized at their highest possible protein concentrations to eliminate 
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potential problems with dilution effects.  When substrates were added to the reaction 
mixture, significant UTP-to-CTP conversion activity was detected in both Phase I and 
Phase II cytoplasmic lysates.  Because the column retained some product during analysis, 
it is impossible to directly compare Phase I and Phase II cytoplasmic lysate activity.  The 
method does prove that Phase II cytoplasmic extract has UTP-to-CTP conversion 
activity.  Due to this observation, we conclude that the Phase II cytoplasmic fraction 
UTP-to-CTP conversion activity, considered with the genetic sequence and protein 
comparison studies, have shown that the Phase II CTP synthase enzyme is active and 
unaffected by the phase transition event.  Therefore, the hypothesis is not supported by 
the available data, and has been shown to be invalid. 
Potential Experiments to examine the cytidine growth phenomenon 
 As the Phase II organisms appear to have an active CTP synthase enzyme, there is 
no current explanation for the cytidine growth phenomenon.  However, there are at least 
three plausible and testable explanations that can be proposed for the Phase II cytidine 
effect.  The possibilities are: (i) The effect is cell-line specific, and cytidine supplements 
the normally poor metabolic components the BHK-21 host cell can make available to the 
avirulent organism, (ii) The higher CO2 levels cause higher acid levels in the acidified 
phagosome of the host cell, creating poor growth conditions for Phase II organisms that 
cytidine may improve, and (iii) Cytidine does not effect Phase II organisms directly, but 
instead causes an effect on the host cell creating a compound or environment more 
suitable to Phase II growth.   
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The cytidine growth phenomenon is cell-line specific 
 Traditionally, Phase II organisms have been considered more efficient in infecting 
host cells and establishing chronic infections of cell lines (Baca et al., 1981; Baca et al., 
1985; Maurin & Raoult, 1999).  It is also known that cell lines have different properties 
due to the genetic mutations that cause their growth immortality (Freshney, 1994).  It has 
been discussed in earlier papers that this property could be exploited to examine 
physiologic and metabolic differences in bacterial mutants (Miller et al., 2004; Turco & 
Winkler, 1982).  To determine if the BHK-21 fibroblast cell line itself is responsible for 
the growth effect, the cytidine growth experiment would need to be performed at 12% 
CO2 with a variety of both phagocytic and non-phagocytic cell lines.  Duplicate cell 
cultures consisting of L929 mouse fibroblasts, BHK-21 hamster fibroblasts, RK-13 rabbit 
fibroblasts, J774 mouse monocytes, and P388D1 mouse macrophage-like cells would be 
equally infected.  Separate infected cell lines would be cultured at 12% CO2 in the 
presence or absence of cytidine.  Parallel sampling using quantitative real time PCR 
would be used to determine the number of C. burnetii organisms per host cell.  
Microscopic examination of stained host cells (Gimenez, 1964), in conjunction with 
PCR, would identify the distribution of infected cells to host cells.  This data set would 
identify whether the growth phenomenon observed in Phase II organisms grown in BHK-
21 cells is unique to that fibroblast cell line. 
Higher CO2 concentrations cause poor Phase II growth conditions 
 It is known that cell lines cultured in higher concentrations of CO2 have 
measurably higher acid levels in their cytoplasm (Freshney, 1994).  It is not known if this 
higher acidity affects C. burnetii growth.  To better understand the effect high 
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concentrations of CO2 have on C. burnetii, duplicate BHK-21 cell cultures would be 
equally infected with Phase I or Phase II organisms.  Duplicate Phase I and Phase II 
tissue culture sets would be set at 5% CO2 and 12% CO2 conditions.  Real-time PCR 
would be utilized to determine the number of C. burnetii organisms per host cell.  
Further, infected cell samples would be loaded with carboxy fluorescein diacetate 
(CFDA), a chemical that measures pH by the change of its fluorescence (Grieshaber et 
al., 2002).  Using this method, the pH of the C. burnetii microenvironment could be 
measured at 5% and 12% CO2.  The information gathered could improve our 
understanding of growth conditions of Phase I and Phase II organisms in the host cell 
acidified phagosome.    
How does the host cell influence cytidine 
 The most directly testable experiments in this project have focused on the effect 
cytidine and cytidine biosynthesis enzymes have on Phase II organisms.  A problem in 
intracellular parasite research is that it is unknown how the host cell influences the flow 
of compounds to C. burnetii organisms.  There is almost no information on how C. 
burnetii influences the host cell, or how the host cell directs metabolic precursors and 
compounds to the occupied acidified phagosome.  Pulse-chase experiments using 14C-
labeled cytidine could give more information on the growth effect.  Separate BHK-21 cell 
cultures would be infected with Phase I and Phase II organisms at equal concentrations 
and cultured at 12% CO2.  The growth medium would be supplemented with 1 mM 
cytidine (including radiolabeled cytidine).  Host cell samples would be removed from 
culture and lysed to release C. burnetii from the host material.  Measuring the 
concentration of radiolabeled material in released C. burnetii would determine whether 
 138
cytidine is being transported and incorporated by the organisms.  It could also be 
determined where the radiolabeled material would be incorporated by isolating and 
assaying C. burnetii DNA, RNA, and protein samples separately.  If the radiolabeled 
compound is in the DNA and RNA fractions, then it suggests (but does not prove) that 
cytidine is unchanged by the host cell.   
CytR repression system 
 As a final note, it must be stated that we do not know if C. burnetii has a CytR 
repression system.  Genetic sequencing and searching for conserved regions in the 
chromosome has identified hypothetical genes with low identity to known E. coli and S. 
typhimurium CytR systems (30% identity).  CytR repression systems in E. coli regulate 
the transcription of at least nine transcriptional units that encode transport proteins and 
enzymes needed for nucleotide catabolism and recycling (Gavigan et al., 1999).  It is 
possible that C. burnetii organisms could have a CytR repression system that is relieved 
by the addition of 1 mM cytidine to the growth medium; however it has yet to be 
definitively identified.  It is also unknown if this would have the same effect on Phase II 
organisms.  It would need to be identified in C. burnetii by sequence compilation and 
comparison first, and then the regulated genes would have to be examined [which could 
be difficult due to the high percentage of hypothetical genes contained in the 
chromosome (Seshadri et al., 2003)].  Until we can prove or disprove the existence of 
CytR in C. burnetii it must remain a possibility that the increased cytidine concentration 
directly relieves the Phase II CytR repressor.   
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